Small animal models of respiratory viral infection related to asthma

Viruses

Volumn 10, Issue 12, 2018, Pages

  Han, Mingyuan ^a   Rajput, Charu ^a   Ishikawa, Tomoko ^a   Jarman, Caitlin R ^a   Lee, Julie ^a   Hershenson, Marc B ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Animal model; Asthma; Respiratory disease; Rhinovirus; Viral infection

Indexed keywords

ALLERGEN; BETA INTERFERON; CHEMOKINE; CXCL1 CHEMOKINE; EOTAXIN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HOUSE DUST ALLERGEN; IMMUNOGLOBULIN E; INTERCELLULAR ADHESION MOLECULE 1; INTERFERON INDUCED HELICASE C DOMAIN CONTAINING PROTEIN 1; INTERFERON REGULATORY FACTOR 7; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 1ALPHA; INTERLEUKIN 25; INTERLEUKIN 33; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; MUCIN; MUCIN 5AC; MUCIN 5B; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNINDEXED DRUG;

ANIMAL MODEL; ASTHMA; BLEEDING; CHRONIC OBSTRUCTIVE LUNG DISEASE; CORONAVIRINAE; COUGHING; DYSPNEA; ENTEROVIRUS D68; EOSINOPHILIA; EXPERIMENTAL MODEL; EXTRACELLULAR TRAP; GENETIC MANIPULATION; GUINEA PIG; HAMSTER; HUMAN; HUMAN PARAINFLUENZA VIRUS 1; HUMAN RESPIRATORY SYNCYTIAL VIRUS; IMMUNE RESPONSE; INFLAMMATION; METAPNEUMOVIRUS; MIDDLE EAST RESPIRATORY SYNDROME; MUSTELA PUTORIUS FURO; MYELITIS; NONHUMAN; PROTEIN EXPRESSION; RESPIRATORY TRACT ALLERGY; REVIEW; RHINOVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; VIRAL RESPIRATORY TRACT INFECTION; VIRUS LOAD; VIRUS PATHOGENESIS; VIRUS REPLICATION; WHEEZING; ANIMAL; COMPLICATION; DISEASE MODEL; MICROFLORA; MOUSE; PATHOGENICITY; RAT; RESPIRATORY TRACT INFECTION; VIROLOGY; VIRUS INFECTION;

ANIMALS; ASTHMA; CRICETINAE; DISEASE MODELS, ANIMAL; FERRETS; GUINEA PIGS; HUMANS; METAPNEUMOVIRUS; MICE; MICROBIOTA; RATS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; RESPIRATORY TRACT INFECTIONS; RHINOVIRUS; VIRUS DISEASES;

EID: 85058345748     PISSN: None     EISSN: 19994915     Source Type: Journal    
DOI: 10.3390/v10120682     Document Type: Review

References (301)

1. Wenzel, S. Severe asthma in adults. Am. J. Respir. Crit. Care Med. 2005, 172, 149–160. [CrossRef] [PubMed]
2. Robinson, D.S.; Hamid, Q.; Ying, S.; Tsicopoulos, A.; Barkans, J.; Bentley, A.M.; Corrigan, C.; Durham, S.R.; Kay, A.B. Predominant TH2-like Bronchoalveolar T-Lymphocyte Population in Atopic Asthma. N. Engl. J. Med. 1992, 326, 298–304. [CrossRef] [PubMed]
3. Woodruff, P.G.; Modrek, B.; Choy, D.F.; Jia, G.; Abbas, A.R.; Ellwanger, A.; Arron, J.R.; Koth, L.L.; Fahy, J.V. T-helper Type 2–driven Inflammation Defines Major Subphenotypes of Asthma. Am. J. Respir. Crit. Care Med. 2009, 180, 388–395. [CrossRef] [PubMed]
4. Bartlett, N.W.; Walton, R.P.; Edwards, M.R.; Aniscenko, J.; Caramori, G.; Zhu, J.; Glanville, N.; Choy, K.J.; Jourdan, P.; Burnet, J.; et al. Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammation. Nat. Med. 2008, 14, 199–204. [CrossRef]
5. Newcomb, D.C.; Sajjan, U.S.; Nagarkar, D.R.; Wang, Q.; Nanua, S.; Zhou, Y.; McHenry, C.L.; Hennrick, K.T.; Tsai, W.C.; Bentley, J.K.; et al. Human rhinovirus 1B exposure induces phosphatidylinositol 3-kinase-dependent airway inflammation in mice. Am. J. Respir. Crit. Care Med. 2008, 177, 1111–1121. [CrossRef] [PubMed]
6. Blanco, J.C.; Core, S.; Pletneva, L.M.; March, T.H.; Boukhvalova, M.S.; Kajon, A.E. Prophylactic Antibody Treatment and Intramuscular Immunization Reduce Infectious Human Rhinovirus 16 Load in the Lower Respiratory Tract of Challenged Cotton Rats. Trials Vaccinol. 2014, 3, 52–60. [CrossRef] [PubMed]
7. Patel, M.C.; Pletneva, L.M.; Boukhvalova, M.S.; Vogel, S.N.; Kajon, A.E.; Blanco, J.C.G. Immunization with Live Human Rhinovirus (HRV) 16 Induces Protection in Cotton Rats against HRV14 Infection. Front. Microbiol. 2017, 8, 1646. [CrossRef]
8. Wei, W.; Guo, H.R.; Chang, J.L.; Yu, Y.Z.; Liu, G.C.; Zhang, N.N.; Willard, S.H.; Zheng, S.; Yu, X.F. ICAM-5/Telencephalin Is a Functional Entry Receptor for Enterovirus D68. Cell Host Microbe 2016, 20, 631–641. [CrossRef]
9. Rajput, C.; Han, M.; Bentley, J.K.; Lei, J.; Ishikawa, T.; Wu, Q.; Hinde, J.L.; Callear, A.P.; Stillwell, T.L.; Jackson, W.T.; et al. Enterovirus D68 infection induces IL-17-dependent neutrophilic airway inflammation and hyperresponsiveness. JCI Insight 2018, 3, 121882. [CrossRef]
10. Hixon, A.M.; Yu, G.; Leser, J.S.; Yagi, S.; Clarke, P.; Chiu, C.Y.; Tyler, K.L. A mouse model of paralytic myelitis caused by enterovirus D68. PLoS Pathog. 2017, 13, e1006199. [CrossRef]
11. Patel, M.C.; Wang, W.; Pletneva, L.M.; Rajagopala, S.V.; Tan, Y.; Hartert, T.V.; Boukhvalova, M.S.; Vogel, S.N.; Das, S.R.; Blanco, J.C. Enterovirus D-68 Infection, Prophylaxis, and Vaccination in a Novel Permissive Animal Model, the Cotton Rat (Sigmodon hispidus). PLoS ONE 2016, 11, e0166336. [CrossRef] [PubMed]
12. Zheng, H.W.; Sun, M.; Guo, L.; Wang, J.J.; Song, J.; Li, J.Q.; Li, H.Z.; Ning, R.T.; Yang, Z.N.; Fan, H.T.; et al. Nasal Infection of Enterovirus D68 Leading to Lower Respiratory Tract Pathogenesis in Ferrets (Mustela putorius furo). Viruses 2017, 9.
13. Prince, G.A.; Horswood, R.L.; Berndt, J.; Suffin, S.C.; Chanock, R.M. Respiratory syncytial virus infection in inbred mice. Infect. Immun. 1979, 26, 764–766. [PubMed]
14. Prince, G.A.; Jenson, A.B.; Horswood, R.L.; Camargo, E.; Chanock, R.M. The pathogenesis of respiratory syncytial virus infection in cotton rats. Am. J. Pathol. 1978, 93, 771–791.
15. Hegele, R.G.; Robinson, P.J.; Gonzalez, S.; Hogg, J.C. Production of acute bronchiolitis in guinea-pigs by human respiratory syncytial virus. Eur. Respir. J. 1993, 6, 1324–1331. [PubMed]
16. Liang, B.; Surman, S.; Amaro-Carambot, E.; Kabatova, B.; Mackow, N.; Lingemann, M.; Yang, L.; McLellan, J.S.; Graham, B.S.; Kwong, P.D.; et al. Enhanced Neutralizing Antibody Response Induced by Respiratory Syncytial Virus Prefusion F Protein Expressed by a Vaccine Candidate. J. Virol. 2015, 89, 9499–9510. [CrossRef]
17. Prince, G.A.; Porter, D.D. The pathogenesis of respiratory syncytial virus infection in infant ferrets. Am. J. Pathol. 1976, 82, 339–352.
18. Dyer, K.D.; Garcia-Crespo, K.E.; Glineur, S.; Domachowske, J.B.; Rosenberg, H.F. The Pneumonia Virus of Mice (PVM) model of acute respiratory infection. Viruses 2012, 4, 3494–3510. [CrossRef]
19. Alvarez, R.; Harrod, K.S.; Shieh, W.J.; Zaki, S.; Tripp, R.A. Human metapneumovirus persists in BALB/c mice despite the presence of neutralizing antibodies. J. Virol. 2004, 78, 14003–14011. [CrossRef]
20. Wyde, P.R.; Chetty, S.N.; Jewell, A.M.; Schoonover, S.L.; Piedra, P.A. Development of a cotton rat-human metapneumovirus (hMPV) model for identifying and evaluating potential hMPV antivirals and vaccines. Antivir. Res. 2005, 66, 57–66. [CrossRef]
21. Williams, J.V.; Tollefson, S.J.; Johnson, J.E.; Crowe, J.E. The cotton rat (Sigmodon hispidus) is a permissive small animal model of human metapneumovirus infection, pathogenesis, and protective immunity. J. Virol. 2005, 79, 10944–10951. [CrossRef] [PubMed]
22. MacPhail, M.; Schickli, J.H.; Tang, R.S.; Kaur, J.; Robinson, C.; Fouchier, R.A.; Osterhaus, A.D.; Spaete, R.R.; Haller, A.A. Identification of small-animal and primate models for evaluation of vaccine candidates for human metapneumovirus (hMPV) and implications for hMPV vaccine design. J. Gen. Virol. 2004, 85, 1655–1663. [CrossRef] [PubMed]
23. Hussell, T.; Openshaw, P.J. Intracellular IFN-gamma expression in natural killer cells precedes lung CD8+ T cell recruitment during respiratory syncytial virus infection. J. Gen. Virol. 1998, 79, 2593–2601. [CrossRef] [PubMed]
24. Porter, D.D.; Prince, G.A.; Hemming, V.G.; Porter, H.G. Pathogenesis of human parainfluenza virus 3 infection in two species of cotton rats: Sigmodon hispidus develops bronchiolitis, while Sigmodon fulviventer develops interstitial pneumonia. J. Virol. 1991, 65, 103–111. [PubMed]
25. Buckner, C.K.; Clayton, D.E.; Ain-Shoka, A.A.; Busse, W.W.; Dick, E.C.; Shult, P. Parainfluenza 3 infection blocks the ability of a beta adrenergic receptor agonist to inhibit antigen-induced contraction of guinea pig isolated airway smooth muscle. J. Clin. Investig. 1981, 67, 376–384. [CrossRef] [PubMed]
26. Buthala, D.A.; Soret, M.G. Parainfluenza Type 3 Virus Infection in Hamsters: Virologic, Serologic, and Pathologic Studies. J. Infect. Dis. 1964, 114, 226–234. [CrossRef] [PubMed]
27. Metzgar, D.P.; Gower, T.A.; Larson, E.J.; Fuscaldo, A.A.; Mascoli, C.C. Effect of Parainfluenza Virus Type-3 on Newborn Ferrets. J. Biol. Stand. 1974, 2, 273–282. [CrossRef]
28. Walter, M.J.; Morton, J.D.; Kajiwara, N.; Agapov, E.; Holtzman, M.J. Viral induction of a chronic asthma phenotype and genetic segregation from the acute response. J. Clin. Investig. 2002, 110, 165–175. [CrossRef]
29. Uhl, E.W.; Castleman, W.L.; Sorkness, R.L.; Busse, W.W.; Lemanske, R.F., Jr.; McAllister, P.K. Parainfluenza virus-induced persistence of airway inflammation, fibrosis, and dysfunction associated with TGF-beta 1 expression in brown Norway rats. Am. J. Respir. Crit. Care Med. 1996, 154, 1834–1842. [CrossRef]
30. Carr, M.J.; Hunter, D.D.; Jacoby, D.B.; Undem, B.J. Expression of tachykinins in nonnociceptive vagal afferent neurons during respiratory viral infection in guinea pigs. Am. J. Respir. Crit. Care Med. 2002, 165, 1071–1075. [CrossRef]
31. Percy, D.H.; Palmer, D.J. Pathogenesis of Sendai virus infection in the Syrian hamster. Lab. Anim. Sci. 1997, 47, 132–137. [PubMed]
32. Teo, S.M.; Mok, D.; Pham, K.; Kusel, M.; Serralha, M.; Troy, N.; Holt, B.J.; Hales, B.J.; Walker, M.L.; Hollams, E.; et al. The Infant Nasopharyngeal Microbiome Impacts Severity of Lower Respiratory Infection and Risk of Asthma Development. Cell Host Microbe 2015, 17, 704–715. [CrossRef] [PubMed]
33. Jackson, D.J.; Evans, M.D.; Gangnon, R.E.; Tisler, C.J.; Pappas, T.E.; Lee, W.M.; Gern, J.E.; Lemanske, R.F. Evidence for a Causal Relationship between Allergic Sensitization and Rhinovirus Wheezing in Early Life. Am. J. Respir. Crit. Care Med. 2012, 185, 281–285. [CrossRef] [PubMed]
34. Caliskan, M.; Bochkov, Y.A.; Kreiner-Moller, E.; Bonnelykke, K.; Stein, M.M.; Du, G.X.; Bisgaard, H.; Jackson, D.J.; Gern, J.E.; Lemanske, R.F.; et al. Rhinovirus Wheezing Illness and Genetic Risk of Childhood-Onset Asthma. N. Engl. J. Med. 2013, 368, 1398–1407. [CrossRef] [PubMed]
35. Johnston, S.L.; Pattemore, P.K.; Sanderson, G.; Smith, S.; Lampe, F.; Josephs, L.; Symington, P.; O’Toole, S.; Myint, S.H.; Tyrrell, D.A.; et al. Community study of role of viral infections in exacerbations of asthma in 9–11 year old children. BMJ 1995, 310, 1225–1229. [CrossRef] [PubMed]
36. Wark, P.A.; Johnston, S.L.; Moric, I.; Simpson, J.L.; Hensley, M.J.; Gibson, P.G. Neutrophil degranulation and cell lysis is associated with clinical severity in virus-induced asthma. Eur. Respir. J. 2002, 19, 68–75. [CrossRef]
37. Heymann, P.W.; Carper, H.T.; Murphy, D.D.; Platts-Mills, T.A.E.; Patrie, J.; McLaughlin, A.P.; Erwin, E.A.; Shaker, M.S.; Hellems, M.; Peerzada, J.; et al. Viral infections in relation to age, atopy, and season of admission among children hospitalized for wheezing. J. Allergy Clin. Immunol. 2004, 114, 239–247. [CrossRef]
38. Roberts, N.; Al Mubarak, R.; Francisco, D.; Kraft, M.; Chu, H.W. Comparison of paired human nasal and bronchial airway epithelial cell responses to rhinovirus infection and IL-13 treatment. Clin. Transl. Med. 2018, 7, 13. [CrossRef]
39. Terajima, M.; Yamaya, M.; Sekizawa, K.; Okinaga, S.; Suzuki, T.; Yamada, N.; Nakayama, K.; Ohrui, T.; Oshima, T.; Numazaki, Y.; et al. Rhinovirus infection of primary cultures of human tracheal epithelium: Role of ICAM-1 and IL-1beta. Am. J. Physiol. 1997, 273, 749–759. [CrossRef]
40. Proud, D.; Sanders, S.P.; Wiehler, S. Human rhinovirus infection induces airway epithelial cell production of human beta-defensin 2 both in vitro and in vivo. J. Immunol. 2004, 172, 4637–4645. [CrossRef]
41. Gern, J.E.; Dick, E.C.; Lee, W.M.; Murray, S.; Meyer, K.; Handzel, Z.T.; Busse, W.W. Rhinovirus enters but does not replicate inside monocytes and airway macrophages. J. Immunol. 1996, 156, 621–627.
42. Akoto, C.; Davies, D.E.; Swindle, E.J. Mast cells are permissive for rhinovirus replication: Potential implications for asthma exacerbations. Clin. Exp. Allergy 2017, 47, 351–360. [CrossRef] [PubMed]
43. Villenave, R.; Thavagnanam, S.; Sarlang, S.; Parker, J.; Douglas, I.; Skibinski, G.; Heaney, L.G.; McKaigue, J.P.; Coyle, P.V.; Shields, M.D.; et al. In vitro modeling of respiratory syncytial virus infection of pediatric bronchial epithelium, the primary target of infection in vivo. Proc. Natl. Acad. Sci. USA 2012, 109, 5040–5045. [CrossRef] [PubMed]
44. Proud, D.; Turner, R.B.; Winther, B.; Wiehler, S.; Tiesman, J.P.; Reichling, T.D.; Juhlin, K.D.; Fulmer, A.W.; Ho, B.Y.; Walanski, A.A.; et al. Gene Expression Profiles during In Vivo Human Rhinovirus Infection: Insights into the Host Response. Am. J. Respir. Crit. Care Med. 2008, 178, 962–968. [CrossRef] [PubMed]
45. Yoon, H.J.; Zhu, Z.; Gwaltney, J.M.; Elias, J.A. Rhinovirus Regulation of IL-1 Receptor Antagonist In Vivo and In Vitro: A Potential Mechanism of Symptom Resolution. J. Immunol. 1999, 162, 7461–7469.
46. Schneider, D.; Hong, J.Y.; Bowman, E.R.; Chung, Y.; Nagarkar, D.R.; McHenry, C.L.; Goldsmith, A.M.; Bentley, J.K.; Lewis, T.C.; Hershenson, M.B. Macrophage/epithelial cell CCL2 contributes to rhinovirus-induced hyperresponsiveness and inflammation in a mouse model of allergic airways disease. Am. J. Physiol. Lung Cell. Mol. Physiol. 2013, 304, L162–L169. [CrossRef] [PubMed]
47. Nagarkar, D.R.; Bowman, E.R.; Schneider, D.; Wang, Q.; Shim, J.; Zhao, Y.; Linn, M.J.; McHenry, C.L.; Gosangi, B.; Bentley, J.K.; et al. Rhinovirus infection of allergen-sensitized and-challenged mice induces eotaxin release from functionally polarized macrophages. J. Immunol. 2010, 185, 2525–2535. [CrossRef]
48. Toussaint, M.; Jackson, D.J.; Swieboda, D.; Guedan, A.; Tsourouktsoglou, T.D.; Ching, Y.M.; Radermecker, C.; Makrinioti, H.; Aniscenko, J.; Bartlett, N.W.; et al. Host DNA released by NETosis promotes rhinovirus-induced type-2 allergic asthma exacerbation. Nat. Med. 2017, 23, 681–691. [CrossRef]
49. Collison, A.; Hatchwell, L.; Verrills, N.; Wark, P.A.; de Siqueira, A.P.; Tooze, M.; Carpenter, H.; Don, A.S.; Morris, J.C.; Zimmermann, N.; et al. The E3 ubiquitin ligase midline 1 promotes allergen and rhinovirus-induced asthma by inhibiting protein phosphatase 2A activity. Nat. Med. 2013, 19, 232–237. [CrossRef]
50. Girkin, J.L.; Hatchwell, L.M.; Collison, A.M.; Starkey, M.R.; Hansbro, P.M.; Yagita, H.; Foster, P.S.; Mattes, J. TRAIL signaling is proinflammatory and proviral in a murine model of rhinovirus 1B infection. Am. J. Physiol. Lung Cell. Mol. Physiol. 2017, 312, L89–L99. [CrossRef]
51. Mukherjee, S.; Rasky, A.J.; Lundy, P.A.; Kittan, N.A.; Kunkel, S.L.; Maillard, I.P.; Kowalski, P.E.; Kousis, P.C.; Guidos, C.J.; Lukacs, N.W. STAT5-induced lunatic fringe during Th2 development alters delta-like 4-mediated Th2 cytokine production in respiratory syncytial virus-exacerbated airway allergic disease. J. Immunol. 2014, 192, 996–1003. [CrossRef] [PubMed]
52. John, A.E.; Berlin, A.A.; Lukacs, N.W. Respiratory syncytial virus-induced CCL5/RANTES contributes to exacerbation of allergic airway inflammation. Eur. J. Immunol. 2003, 33, 1677–1685. [CrossRef] [PubMed]
53. Schneider, D.; Hong, J.Y.; Popova, A.P.; Bowman, E.R.; Linn, M.J.; McLean, A.M.; Zhao, Y.; Sonstein, J.; Bentley, J.K.; Weinberg, J.B.; et al. Neonatal rhinovirus infection induces mucous metaplasia and airways hyperresponsiveness. J. Immunol. 2012, 188, 2894–2904. [CrossRef]
54. You, D.; Siefker, D.T.; Shrestha, B.; Saravia, J.; Cormier, S.A. Building a better neonatal mouse model to understand infant respiratory syncytial virus disease. Respir. Res. 2015, 16, 91. [CrossRef] [PubMed]
55. Han, M.; Rajput, C.; Hong, J.Y.; Lei, J.; Hinde, J.L.; Wu, Q.; Bentley, J.K.; Hershenson, M.B. The Innate Cytokines IL-25, IL-33, and TSLP Cooperate in the Induction of Type 2 Innate Lymphoid Cell Expansion and Mucous Metaplasia in Rhinovirus-Infected Immature Mice. J. Immunol. 2017, 199, 1308–1318. [CrossRef] [PubMed]
56. Hong, J.Y.; Bentley, J.K.; Chung, Y.T.; Lei, J.; Steenrod, J.M.; Chen, Q.; Sajjan, U.S.; Hershenson, M.B. Neonatal rhinovirus induces mucous metaplasia and airways hyperresponsiveness through IL-25 and type 2 innate lymphoid cells. J. Allergy Clin. Immunol. 2014, 134, 429–439. [CrossRef] [PubMed]
57. Stark, J.M.; McDowell, S.A.; Koenigsknecht, V.; Prows, D.R.; Leikauf, J.E.; Le Vine, A.M.; Leikauf, G.D. Genetic susceptibility to respiratory syncytial virus infection in inbred mice. J. Med. Virol. 2002, 67, 92–100. [CrossRef] [PubMed]
58. Taylor, G.; Stott, E.J.; Hughes, M.; Collins, A.P. Respiratory syncytial virus infection in mice. Infect. Immun. 1984, 43, 649–655. [PubMed]
59. Anderson, J.J.; Norden, J.; Saunders, D.; Toms, G.L.; Scott, R. Analysis of the local and systemic immune responses induced in BALB/c mice by experimental respiratory syncytial virus infection. J. Gen. Virol. 1990, 71, 1561–1570. [CrossRef]
60. Graham, B.S.; Perkins, M.D.; Wright, P.F.; Karzon, D.T. Primary respiratory syncytial virus infection in mice. J. Med. Virol. 1988, 26, 153–162. [CrossRef]
61. Culley, F.J.; Pollott, J.; Openshaw, P.J.M. Age at first viral infection determines the pattern of T cell-mediated disease during reinfection in adulthood. J. Exp. Med. 2002, 196, 1381–1386. [CrossRef] [PubMed]
62. Hussell, T.; Baldwin, C.J.; O’Garra, A.; Openshaw, P.J.M. CD8(+) T cells control Th2-driven pathology during pulmonary respiratory syncytial virus infection. Eur. J. Immunol. 1997, 27, 3341–3349. [CrossRef] [PubMed]
63. Openshaw, P.J.M.; Clarke, S.L.; Record, F.M. Pulmonary Eosinophilic Response to Respiratory Syncytial Virus-Infection in Mice Sensitized to the Major Surface Glycoprotein-G. Int. Immunol. 1992, 4, 493–500. [CrossRef] [PubMed]
64. Connors, M.; Giese, N.A.; Kulkarni, A.B.; Firestone, C.Y.; Morse, H.C.; Murphy, B.R. Enhanced Pulmonary Histopathology Induced by Respiratory Syncytial Virus (Rsv) Challenge of Formalin-Inactivated Rsv-Immunized Balb/C Mice Is Abrogated by Depletion of Interleukin-4 (Il-4) and Il-10. J. Virol. 1994, 68, 5321–5325. [PubMed]
65. Stokes, K.L.; Chi, M.H.; Sakamoto, K.; Newcomb, D.C.; Currier, M.G.; Huckabee, M.M.; Lee, S.; Goleniewska, K.; Pretto, C.; Williams, J.V.; et al. Differential pathogenesis of respiratory syncytial virus clinical isolates in BALB/c mice. J. Virol. 2011, 85, 5782–5793. [CrossRef] [PubMed]
66. Stier, M.T.; Bloodworth, M.H.; Toki, S.; Newcomb, D.C.; Goleniewska, K.; Boyd, K.L.; Quitalig, M.; Hotard, A.L.; Moore, M.L.; Hartert, T.V.; et al. Respiratory syncytial virus infection activates IL-13-producing group 2 innate lymphoid cells through thymic stromal lymphopoietin. J. Allergy Clin. Immunol. 2016, 138, 814–824. [CrossRef] [PubMed]
67. Liu, Y.R.; Haas, D.L.; Poore, S.; Isakovic, S.; Gahan, M.; Mahalingam, S.; Fu, Z.F.; Tripp, R.A. Human Metapneumovirus Establishes Persistent Infection in the Lungs of Mice and Is Reactivated by Glucocorticoid Treatment. J. Virol. 2009, 83, 6837–6848. [CrossRef]
68. Hamelin, M.E.; Yim, K.; Kuhn, K.H.; Cragin, R.P.; Boukhvalova, M.; Blanco, J.C.G.; Prince, G.A.; Boivin, G. Pathogenesis of human metapneumovirus lung infection in BALB/c mice and cotton rats. J. Virol. 2005, 79, 8894–8903. [CrossRef]
69. Hamelin, M.E.; Prince, G.A.; Gomez, A.M.; Kinkead, R.; Boivin, G. Human metapneumovirus infection induces long-term pulmonary inflammation associated with airway obstruction and hyperresponsiveness in mice. J. Infect. Dis. 2006, 193, 1634–1642. [CrossRef]
70. Walter, M.J.; Kajiwara, N.; Karanja, P.; Castro, M.; Holtzman, M.J. Interleukin 12 p40 production by barrier epithelial cells during airway inflammation. J. Exp. Med. 2001, 193, 339–351. [CrossRef]
71. Tyner, J.W.; Uchida, O.; Kajiwara, N.; Kim, E.Y.; Patel, A.C.; O’Sullivan, M.P.; Walter, M.J.; Schwendener, R.A.; Cook, D.N.; Danoff, T.M.; et al. CCL5-CCR5 interaction provides antiapoptotic signals for macrophage survival during viral infection. Nat. Med. 2005, 11, 1180–1187. [CrossRef]
72. Stephens, R.; Randolph, D.A.; Huang, G.M.; Holtzman, M.J.; Chaplin, D.D. Antigen-nonspecific recruitment of Th2 cells to the lung as a mechanism for viral infection-induced allergic asthma. J. Immunol. 2002, 169, 5458–5467. [CrossRef] [PubMed]
73. Hegele, R.G.; Hayashi, S.; Bramley, A.M.; Hogg, J.C. Persistence of respiratory syncytial virus genome and protein after acute bronchiolitis in guinea pigs. Chest 1994, 105, 1848–1854. [CrossRef] [PubMed]
74. Castleman, W.L.; Brundage-Anguish, L.J.; Kreitzer, L.; Neuenschwander, S.B. Pathogenesis of bronchiolitis and pneumonia induced in neonatal and weanling rats by parainfluenza (Sendai) virus. Am. J. Pathol. 1987, 129, 277–286. [PubMed]
75. Castleman, W.L.; Owens, S.B.; Brundage-Anguish, L.J. Acute and persistent alterations in pulmonary inflammatory cells and airway mast cells induced by Sendai virus infection in neonatal rats. Vet. Pathol. 1989, 26, 18–25. [CrossRef] [PubMed]
76. Sorkness, R.; Clough, J.J.; Castleman, W.L.; Lemanske, R.F., Jr. Virus-induced airway obstruction and parasympathetic hyperresponsiveness in adult rats. Am. J. Respir. Crit. Care Med. 1994, 150, 28–34. [CrossRef] [PubMed]
77. Sorkness, R.; Lemanske, R.F.; Castleman, W.L. Persistent Airway Hyperresponsiveness after Neonatal Viral Bronchiolitis in Rats. J. Appl. Physiol. 1991, 70, 375–383. [CrossRef]
78. Hadfield, A.T.; Lee, W.M.; Zhao, R.; Oliveira, M.A.; Minor, I.; Rueckert, R.R.; Rossmann, M.G. The refined structure of human rhinovirus 16 at 2.15 angstrom resolution: Implications for the viral life cycle. Structure 1997, 5, 427–441. [CrossRef]
79. Stanway, G.; Hughes, P.J.; Mountford, R.C.; Minor, P.D.; Almond, J.W. The Complete Nucleotide-Sequence of a Common Cold Virus—Human Rhinovirus 14. Nucleic Acids Res. 1984, 12, 7859–7875. [CrossRef]
80. Palmenberg, A.C.; Gern, J.E. Classification and Evolution of Human Rhinoviruses. In Rhinoviruses: Methods and Protocols; Jans, D.A., Ghildyal, R., Eds.; Springer: New York, NY, USA, 2015; pp. 1–10.
81. Greve, J.M.; Davis, G.; Meyer, A.M.; Forte, C.P.; Yost, S.C.; Marior, C.W.; Kamarck, M.E.; Mcclelland, A. The Major Human Rhinovirus Receptor Is Icam-1. Cell 1989, 56, 839–847. [CrossRef]
82. Staunton, D.E.; Merluzzi, V.J.; Rothlein, R.; Barton, R.; Marlin, S.D.; Springer, T.A. A Cell-Adhesion Molecule, Icam-1, Is the Major Surface-Receptor for Rhinoviruses. Cell 1989, 56, 849–853. [CrossRef]
83. Tomassini, J.E.; Graham, D.; Dewitt, C.M.; Lineberger, D.W.; Rodkey, J.A.; Colonno, R.J. Cdna Cloning Reveals That the Major Group Rhinovirus Receptor on Hela-Cells Is Intercellular-Adhesion Molecule-1. Proc. Natl. Acad. Sci. USA 1989, 86, 4907–4911. [CrossRef] [PubMed]
84. Vlasak, M.; Roivainen, M.; Reithmayer, M.; Goesler, I.; Laine, P.; Snyers, L.; Hovi, T.; Blaas, D. The minor receptor group of human rhinovirus (HRV) includes HRV23 and HRV25, but the presence of a lysine in the VP1 HI loop is not sufficient for receptor binding. J. Virol. 2005, 79, 7389–7395. [CrossRef] [PubMed]
85. Lau, S.K.; Yip, C.C.; Woo, P.C.; Yuen, K.Y. Human rhinovirus C: A newly discovered human rhinovirus species. Emerg. Health Threats J. 2010, 3, e2. [CrossRef] [PubMed]
86. Bochkov, Y.A.; Watters, K.; Ashraf, S.; Griggs, T.F.; Devries, M.K.; Jackson, D.J.; Palmenberg, A.C.; Gern, J.E. Cadherin-related family member 3, a childhood asthma susceptibility gene product, mediates rhinovirus C binding and replication. Proc. Natl. Acad. Sci. USA 2015, 112, 5485–5490. [CrossRef] [PubMed]
87. Jacobs, S.E.; Lamson, D.M.; St George, K.; Walsh, T.J. Human rhinoviruses. Clin. Microbiol. Rev. 2013, 26, 135–162. [CrossRef] [PubMed]
88. Arruda, E.; Pitkaranta, A.; Witek, T.J.; Doyle, C.A.; Hayden, F.G. Frequency and natural history of rhinovirus infections in adults during autumn. J. Clin. Microbiol. 1997, 35, 2864–2868. [PubMed]
89. Arruda, E.; Boyle, T.R.; Winther, B.; Pevear, D.C.; Gwaltney, J.M.; Hayden, F.G. Localization of Human Rhinovirus Replication in the Upper Respiratory Tract by In Situ Hybridization. J. Infect. Dis. 1995, 171, 1329–1333. [CrossRef] [PubMed]
90. Gern, J.E.; Galagan, D.M.; Jarjour, N.N.; Dick, E.C.; Busse, W.W. Detection of rhinovirus RNA in lower airway cells during experimentally induced infection. Am. J. Respir. Crit. Care Med. 1997, 155, 1159–1161. [CrossRef] [PubMed]
91. Gern, J.E.; Calhoun, W.; Swenson, C.; Shen, G.; Busse, W.W. Rhinovirus infection preferentially increases lower airway responsiveness in allergic subjects. Am. J. Respir. Crit. Care Med. 1997, 155, 1872–1876. [CrossRef]
92. Mosser, A.G.; Vrtis, R.; Burchell, L.; Lee, W.-M.; Dick, C.R.; Weisshaar, E.; Bock, D.; Swenson, C.A.; Cornwell, R.D.; Meyer, K.C.; et al. Quantitative and Qualitative Analysis of Rhinovirus Infection in Bronchial Tissues. Am. J. Respir. Crit. Care Med. 2005, 171, 645–651. [CrossRef] [PubMed]
93. Papadopoulos, N.G.; Bates, P.J.; Bardin, P.G.; Papi, A.; Leir, S.H.; Fraenkel, D.J.; Meyer, J.; Lackie, P.M.; Sanderson, G.; Holgate, S.T.; et al. Rhinoviruses infect the lower airways. J. Infect. Dis. 2000, 181, 1875–1884. [CrossRef] [PubMed]
94. Wos, M.; Sanak, M.; Soja, J.; Olechnowicz, H.; Busse, W.W.; Szczeklik, A. The Presence of Rhinovirus in Lower Airways of Patients with Bronchial Asthma. Am. J. Respir. Crit. Care Med. 2008, 177, 1082–1089. [CrossRef]
95. Mosser, A.G.; Brockman-Schneider, R.; Amineva, S.; Burchell, L.; Sedgwick, J.B.; Busse, W.W.; Gern, J.E. Similar frequency of rhinovirus-infectible cells in upper and lower airway epithelium. J. Infect. Dis. 2002, 185, 734–743. [CrossRef] [PubMed]
96. DeMore, J.P.; Weisshaar, E.H.; Vrtis, R.F.; Swenson, C.A.; Evans, M.D.; Morin, A.; Hazel, E.; Bork, J.A.; Kakumanu, S.; Sorkness, R.; et al. Similar colds in subjects with allergic asthma and nonatopic subjects after inoculation with rhinovirus-16. J. Allergy Clin. Immunol. 2009, 124, 245–252. [CrossRef] [PubMed]
97. Johnston, N.W.; Johnston, S.L.; Duncan, J.M.; Greene, J.M.; Kebadze, T.; Keith, P.K.; Roy, M.; Waserman, S.; Sears, M.R. The September epidemic of asthma exacerbations in children: A search for etiology. J. Allergy Clin. Immunol. 2005, 115, 132–138. [CrossRef] [PubMed]
98. Nicholson, K.G.; Kent, J.; Ireland, D.C. Respiratory viruses and exacerbations of asthma in adults. BMJ 1993, 307, 982–986. [CrossRef]
99. Tan, W.C.; Xiang, X.; Qiu, D.; Ng, T.P.; Lam, S.F.; Hegele, R.G. Epidemiology of respiratory viruses in patients hospitalized with near-fatal asthma, acute exacerbations of asthma, or chronic obstructive pulmonary disease*1. Am. J. Med. 2003, 115, 272–277. [CrossRef]
100. Green, R.H.; Brightling, C.E.; McKenna, S.; Hargadon, B.; Parker, D.; Bradding, P.; Wardlaw, A.J.; Pavord, I.D. Asthma exacerbations and sputum eosinophil counts: A randomised controlled trial. Lancet 2002, 360, 1715–1721. [CrossRef]
101. Kistler, A.; Avila, P.C.; Rouskin, S.; Wang, D.; Ward, T.; Yagi, S.; Schnurr, D.; Ganem, D.; DeRisi, J.L.; Boushey, H.A. Pan-Viral Screening of Respiratory Tract Infections in Adults with and without Asthma Reveals Unexpected Human Coronavirus and Human Rhinovirus Diversity. J. Infect. Dis. 2007, 196, 817–825. [CrossRef]
102. Harju, T.H.; Leinonen, M.; Nokso-Koivisto, J.; Korhonen, T.; Räty, R.; He, Q.; Hovi, T.; Mertsola, J.; Bloigu, A.; Rytilä, P.; et al. Pathogenic bacteria and viruses in induced sputum or pharyngeal secretions of adults with stable asthma. Thorax 2006, 61, 579–584. [CrossRef] [PubMed]
103. Atmar, R.L.; Guy, E.; Guntupalli, K.K.; Zimmerman, J.L.; Bandi, V.D.; Baxter, B.D.; Greenberg, S.B. Respiratory tract viral infections in inner-city asthmatic adults. Arch. Intern. Med. 1998, 158, 2453–2459. [CrossRef] [PubMed]
104. Khetsuriani, N.; Kazerouni, N.N.; Erdman, D.D.; Lu, X.; Redd, S.C.; Anderson, L.J.; Teague, W.G. Prevalence of viral respiratory tract infections in children with asthma. J. Allergy Clin. Immunol. 2007, 119, 314–321. [CrossRef] [PubMed]
105. Greenberg, S.B.; Allen, M.; Wilson, J.; Atmar, R.L. Respiratory viral infections in adults with and without chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2000, 162, 167–173. [CrossRef] [PubMed]
106. Seemungal, T.; Harper-Owen, R.; Bhowmik, A.; Moric, I.; Sanderson, G.; Message, S.; Maccallum, P.; Meade, T.W.; Jeffries, D.J.; Johnston, S.L.; et al. Respiratory Viruses, Symptoms, and Inflammatory Markers in Acute Exacerbations and Stable Chronic Obstructive Pulmonary Disease. Am. J. Respir. Crit. Care Med. 2001, 164, 1618–1623. [CrossRef] [PubMed]
107. Rohde, G.; Wiethege, A.; Borg, I.; Kauth, M.; Bauer, T.T.; Gillissen, A.; Bufe, A.; Schultze-Werninghaus, G. Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: A case-control study. Thorax 2003, 58, 37–42. [CrossRef] [PubMed]
108. Ko, F.W.S.; Ip, M.; Chan, P.K.S.; Fok, J.P.C.; Chan, M.C.H.; Ngai, J.C.; Chan, D.P.S.; Hui, D.S.C. A 1-Year Prospective Study of the Infectious Etiology in Patients Hospitalized with Acute Exacerbations of COPD. Chest 2007, 131, 44–52. [CrossRef]
109. McManus, T.E.; Marley, A.-M.; Baxter, N.; Christie, S.N.; O’Neill, H.J.; Elborn, J.S.; Coyle, P.V.; Kidney, J.C. Respiratory viral infection in exacerbations of COPD. Respir. Med. 2008, 102, 1575–1580. [CrossRef]
110. Kling, S.; Donninger, H.; Williams, Z.; Vermeulen, J.; Weinberg, E.; Latiff, K.; Ghildyal, R.; Bardin, P. Persistence of rhinovirus RNA after asthma exacerbation in children. Clin. Exp. Allergy 2005, 35, 672–678. [CrossRef]
111. Corne, J.M.; Marshall, C.; Smith, S.; Schreiber, J.; Sanderson, G.; Holgate, S.T.; Johnston, S.L. Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: A longitudinal cohort study. Lancet 2002, 359, 831–834. [CrossRef]
112. Kotaniemi-Syrjanen, A.; Vainionpaa, R.; Reijonen, T.M.; Waris, M.; Korhonen, K.; Korppi, M. Rhinovirus-induced wheezing in infancy–the first sign of childhood asthma? J. Allergy Clin. Immunol. 2003, 111, 66–71. [CrossRef] [PubMed]
113. Lemanske, R.F., Jr.; Jackson, D.J.; Gangnon, R.E.; Evans, M.D.; Li, Z.; Shult, P.A.; Kirk, C.J.; Reisdorf, E.; Roberg, K.A.; Anderson, E.L.; et al. Rhinovirus illnesses during infancy predict subsequent childhood wheezing. J. Allergy Clin. Immunol. 2005, 116, 571–577. [CrossRef] [PubMed]
114. Jackson, D.J.; Gangnon, R.E.; Evans, M.D.; Roberg, K.A.; Anderson, E.L.; Pappas, T.E.; Printz, M.C.; Lee, W.M.; Shult, P.A.; Reisdorf, E.; et al. Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children. Am. J. Respir. Crit. Care Med. 2008, 178, 667–672. [CrossRef] [PubMed]
115. Rubner, F.J.; Jackson, D.J.; Evans, M.D.; Gangnon, R.E.; Tisler, C.J.; Pappas, T.E.; Gern, J.E.; Lemanske, R.F. Early life rhinovirus wheezing, allergic sensitization, and asthma risk at adolescence. J. Allergy Clin. Immunol. 2017, 139, 501–507. [CrossRef] [PubMed]
116. Harris, J.R.; Racaniello, V.R. Changes in rhinovirus protein 2C allow efficient replication in mouse cells. J. Virol. 2003, 77, 4773–4780. [CrossRef] [PubMed]
117. Tuthill, T.J.; Papadopoulos, N.G.; Jourdan, P.; Challinor, L.J.; Sharp, N.A.; Plumpton, C.; Shah, K.; Barnard, S.; Dash, L.; Burnet, J.; et al. Mouse respiratory epithelial cells support efficient replication of human rhinovirus. J. Gen. Virol. 2003, 84, 2829–2836. [CrossRef] [PubMed]
118. Reithmayer, M.; Reischl, A.; Snyers, L.; Blaas, D. Species-specific receptor recognition by a minor-group human rhinovirus (HRV): HRV serotype 1A distinguishes between the murine and the human low-density lipoprotein receptor. J. Virol. 2002, 76, 6957–6965. [CrossRef]
119. Rasmussen, A.L.; Racaniello, V.R. Selection of rhinovirus 1A variants adapted for growth in mouse lung epithelial cells. Virology 2011, 420, 82–88. [CrossRef]
120. Foxman, E.F.; Storer, J.A.; Fitzgerald, M.E.; Wasik, B.R.; Hou, L.; Zhao, H.Y.; Turner, P.E.; Pyle, A.M.; Iwasaki, A. Temperature-dependent innate defense against the common cold virus limits viral replication at warm temperature in mouse airway cells. Proc. Natl. Acad. Sci. USA 2015, 112, 827–832. [CrossRef]
121. Nagarkar, D.R.; Wang, Q.; Shim, J.; Zhao, Y.; Tsai, W.C.; Lukacs, N.W.; Sajjan, U.; Hershenson, M.B. CXCR2 Is Required for Neutrophilic Airway Inflammation and Hyperresponsiveness in a Mouse Model of Human Rhinovirus Infection. J. Immunol. 2009, 183, 6698–6707. [CrossRef]
122. Wang, Q.; Miller, D.J.; Bowman, E.R.; Nagarkar, D.R.; Schneider, D.; Zhao, Y.; Linn, M.J.; Goldsmith, A.M.; Bentley, J.K.; Sajjan, U.S.; et al. MDA5 and TLR3 Initiate Pro-Inflammatory Signaling Pathways Leading to Rhinovirus-Induced Airways Inflammation and Hyperresponsiveness. PLoS Pathog. 2011, 7, e1002070. [CrossRef] [PubMed]
123. Girkin, J.; Hatchwell, L.; Foster, P.; Johnston, S.L.; Bartlett, N.; Collison, A.; Mattes, J. CCL7 and IRF-7 Mediate Hallmark Inflammatory and IFN Responses following Rhinovirus 1B Infection. J. Immunol. 2015, 194, 4924–4930. [CrossRef] [PubMed]
124. Han, M.; Chung, Y.; Young Hong, J.; Rajput, C.; Lei, J.; Hinde, J.L.; Chen, Q.; Weng, S.P.; Bentley, J.K.; Hershenson, M.B. Toll-like receptor 2-expressing macrophages are required and sufficient for rhinovirus-induced airway inflammation. J. Allergy Clin. Immunol. 2016, 138, 1619–1630. [CrossRef] [PubMed]
125. Glanville, N.; Peel, T.J.; Schroder, A.; Aniscenko, J.; Walton, R.P.; Finotto, S.; Johnston, S.L. Tbet Deficiency Causes T Helper Cell Dependent Airways Eosinophilia and Mucus Hypersecretion in Response to Rhinovirus Infection. PLoS Pathog. 2016, 12, e1005913. [CrossRef] [PubMed]
126. Chung, Y.; Hong, J.Y.; Lei, J.; Chen, Q.; Bentley, J.K.; Hershenson, M.B. Rhinovirus Infection Induces IL-13 Production from CD11b-positive, Exudative M2-polarized Exudative Macrophages. Am. J. Respir. Cell Mol. Biol. 2015, 52, 205–216. [CrossRef] [PubMed]
127. Bentley, J.K.; Sajjan, U.S.; Dzaman, M.B.; Jarjour, N.N.; Lee, W.M.; Gern, J.E.; Hershenson, M.B. Rhinovirus colocalizes with CD68-and CD11b-positive macrophages following experimental infection in humans. J. Allergy Clin. Immunol. 2013, 132, 758–761. [CrossRef] [PubMed]
128. Mehta, A.K.; Duan, W.; Doerner, A.M.; Traves, S.L.; Broide, D.H.; Proud, D.; Zuraw, B.L.; Croft, M. Rhinovirus infection interferes with induction of tolerance to aeroantigens through OX40 ligand, thymic stromal lymphopoietin, and IL-33. J. Allergy Clin. Immunol. 2016, 137, 278–288. [CrossRef] [PubMed]
129. Chairakaki, A.-D.; Saridaki, M.-I.; Pyrillou, K.; Mouratis, M.-A.; Koltsida, O.; Walton, R.P.; Bartlett, N.W.; Stavropoulos, A.; Boon, L.; Rovina, N.; et al. Plasmacytoid dendritic cells drive acute asthma exacerbations. J. Allergy Clin. Immunol. 2018, 142, 542–556. [CrossRef]
130. Phan, J.A.; Kicic, A.; Berry, L.J.; Fernandes, L.B.; Zosky, G.R.; Sly, P.D.; Larcombe, A.N. Rhinovirus exacerbates house-dust-mite induced lung disease in adult mice. PLoS ONE 2014, 9, e92163. [CrossRef]
131. Hatchwell, L.; Collison, A.; Girkin, J.; Parsons, K.; Li, J.Y.; Zhang, J.; Phipps, S.; Knight, D.; Bartlett, N.W.; Johnston, S.L.; et al. Toll-like receptor 7 governs interferon and inflammatory responses to rhinovirus and is suppressed by IL-5-induced lung eosinophilia. Thorax 2015, 70, 854–861. [CrossRef]
132. Han, M.; Hong, J.Y.; Jaipalli, S.; Rajput, C.; Lei, J.; Hinde, J.L.; Chen, Q.; Hershenson, N.M.; Bentley, J.K.; Hershenson, M.B. IFN-gamma Blocks Development of an Asthma Phenotype in Rhinovirus-Infected Baby Mice by Inhibiting Type 2 Innate Lymphoid Cells. Am. J. Respir. Cell Mol. Biol. 2017, 56, 242–251. [PubMed]
133. Lachowicz-Scroggins, M.E.; Boushey, H.A.; Finkbeiner, W.E.; Widdicombe, J.H. Interleukin-13-Induced Mucous Metaplasia Increases Susceptibility of Human Airway Epithelium to Rhinovirus Infection. Am. J. Respir. Cell Mol. Biol. 2010, 43, 652–661. [CrossRef] [PubMed]
134. Rajput, C.; Cui, T.; Han, M.Y.; Lei, J.; Hinde, J.L.; Wu, Q.; Bentley, J.K.; Hershenson, M.B. ROR alpha-dependent type 2 innate lymphoid cells are required and sufficient for mucous metaplasia in immature mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 2017, 312, L983–L993. [CrossRef] [PubMed]
135. Schieble, J.H.; Fox, V.L.; Lennette, E.H. A probable new human picornavirus associated with respiratory diseases. Am. J. Epidemiol. 1967, 85, 297–310. [CrossRef] [PubMed]
136. Tokarz, R.; Firth, C.; Madhi, S.A.; Howie, S.R.C.; Wu, W.; Sall, A.A.; Haq, S.; Briese, T.; Lipkin, W.I. Worldwide emergence of multiple clades of enterovirus 68. J. Gen. Virol. 2012, 93, 1952–1958. [CrossRef] [PubMed]
137. Ikeda, T.; Mizuta, K.; Abiko, C.; Aoki, Y.; Itagaki, T.; Katsushima, F.; Katsushima, Y.; Matsuzaki, Y.; Fuji, N.; Imamura, T.; et al. Acute respiratory infections due to enterovirus 68 in Yamagata, Japan between 2005 and 2010. Microbiol. Immunol. 2012, 56, 139–143. [CrossRef]
138. Lu, Q.B.; Wo, Y.; Wang, H.Y.; Wei, M.T.; Zhang, L.; Yang, H.; Liu, E.M.; Li, T.Y.; Zhao, Z.T.; Liu, W.; et al. Detection of enterovirus 68 as one of the commonest types of enterovirus found in patients with acute respiratory tract infection in China. J. Med. Microbiol. 2014, 63, 408–414. [CrossRef]
139. Meijer, A.; Benschop, K.S.; Donker, G.A.; van der Avoort, H.G. Continued seasonal circulation of enterovirus D68 in the Netherlands, 2011–2014. Eurosurveillance 2014, 19, 2–7. [CrossRef]
140. Meijer, A.; van der Sanden, S.; Snijders, B.E.P.; Jaramillo-Gutierrez, G.; Bont, L.; van der Ent, C.K.; Overduin, P.; Jenny, S.L.; Jusic, E.; van der Avoort, H.G.A.M.; et al. Emergence and epidemic occurrence of enterovirus 68 respiratory infections in The Netherlands in 2010. Virology 2012, 423, 49–57. [CrossRef]
141. Imamura, T.; Suzuki, A.; Meijer, A.; Niesters, H.G.M.; Rahamat-Langendoen, J.C.; Lojo, J.; Hodinka, R.L.; Coffin, S.; Ostroff, S.M.; Kraft, C.S.; et al. Clusters of Acute Respiratory Illness Associated with Human Enterovirus 68-Asia, Europe, and United States, 2008–2010 (Reprinted from MMWR, vol 60, pg 1301–1304, 2011). JAMA J. Am. Med. Assoc. 2011, 306, 1971–1973.
142. Midgley, C.M.; Watson, J.T.; Nix, W.A.; Curns, A.T.; Rogers, S.L.; Brown, B.A.; Conover, C.; Dominguez, S.R.; Feikin, D.R.; Gray, S.; et al. Severe respiratory illness associated with a nationwide outbreak of enterovirus D68 in the USA (2014): A descriptive epidemiological investigation. Lancet Respir. Med. 2015, 3, 879–887. [CrossRef]
143. Messacar, K.; Abzug, M.J.; Dominguez, S.R. 2014 outbreak of enterovirus D68 in North America. J. Med. Virol. 2016, 88, 739–745. [CrossRef]
144. Rao, S.; Messacar, K.; Torok, M.R.; Rick, A.M.; Holzberg, J.; Montano, A.; Bagdure, D.; Curtis, D.J.; Oberste, M.S.; Nix, W.A.; et al. Enterovirus D68 in Critically Ill Children: A Comparison with Pandemic H1N1 Influenza. Pediatr. Crit. Care Med. 2016, 17, 1023–1031. [CrossRef]
145. Abedi, G.R.; Watson, J.T.; Nix, W.A.; Oberste, M.S.; Gerber, S.I. Enterovirus and Parechovirus Surveillance—United States, 2014–2016. MMWR Morb. Mortal. Wkly. Rep. 2018, 67, 515–518. [CrossRef] [PubMed]
146. Leshem, E. Acute Flaccid Myelitis among Persons Aged <= 21 Years—United States, August 1–November 13, 2014. MMWR Morb. Mortal. Wkly. Rep. 2015, 63, 1243–1244.
147. Greninger, A.L.; Naccache, S.N.; Messacar, K.; Clayton, A.; Yu, G.X.; Somasekar, S.; Federman, S.; Stryke, D.; Anderson, C.; Yagi, S.; et al. A novel outbreak enterovirus D68 strain associated with acute flaccid myelitis cases in the USA (2012–14): A retrospective cohort study. Lancet Infect. Dis. 2015, 15, 671–682. [CrossRef]
148. Aliabadi, N.; Messacar, K.; Pastula, D.M.; Robinson, C.C.; Leshem, E.; Sejvar, J.J.; Nix, W.A.; Oberste, M.S.; Feikin, D.R.; Dominguez, S.R. Enterovirus D68 Infection in Children with Acute Flaccid Myelitis, Colorado, USA, 2014. Emerg. Infect. Dis. 2016, 22, 1387–1394. [CrossRef]
149. Du, J.; Zheng, B.; Zheng, W.; Li, P.; Kang, J.; Hou, J.; Markham, R.; Zhao, K.; Yu, X.F. Analysis of Enterovirus 68 Strains from the 2014 North American Outbreak Reveals a New Clade, Indicating Viral Evolution. PLoS ONE 2015, 10, e0144208. [CrossRef] [PubMed]
150. Liu, Y.; Sheng, J.; Fokine, A.; Meng, G.; Shin, W.H.; Long, F.; Kuhn, R.J.; Kihara, D.; Rossmann, M.G. Structure and inhibition of EV-D68, a virus that causes respiratory illness in children. Science 2015, 347, 71–74. [CrossRef]
151. Oberste, M.S.; Maher, K.; Schnurr, D.; Flemister, M.R.; Lovchik, J.C.; Peters, H.; Sessions, W.; Kirk, C.; Chatterjee, N.; Fuller, S.; et al. Enterovirus 68 is associated with respiratory illness and shares biological features with both the enteroviruses and the rhinoviruses. J. Gen. Virol. 2004, 85, 2577–2584. [CrossRef]
152. Savolainen, C.; Blomqvist, S.; Mulders, M.N.; Hovi, T. Genetic clustering of all 102 human rhinovirus prototype strains: Serotype 87 is close to human enterovirus 70. J. Gen. Virol. 2002, 83, 333–340. [CrossRef] [PubMed]
153. Ishiko, H.; Miura, R.; Shimada, Y.; Hayashi, A.; Nakajima, H.; Yamazaki, S.; Takeda, N. Human Rhinovirus 87 Identified as Human Enterovirus 68 by VP4-Based Molecular Diagnosis. Intervirology 2002, 45, 136–141. [CrossRef] [PubMed]
154. Blomqvist, S.; Savolainen, C.; Raman, L.; Roivainen, M.; Hovi, T. Human rhinovirus 87 and enterovirus 68 represent a unique serotype with rhinovirus and enterovirus features. J. Clin. Microbiol. 2002, 40, 4218–4223. [CrossRef] [PubMed]
155. Liu, Y.; Sheng, J.; Baggen, J.; Meng, G.; Xiao, C.; Thibaut, H.J.; van Kuppeveld, F.J.; Rossmann, M.G. Sialic acid-dependent cell entry of human enterovirus D68. Nat. Commun. 2015, 6, 8865. [CrossRef] [PubMed]
156. Baggen, J.; Thibaut, H.J.; Staring, J.; Jae, L.T.; Liu, Y.; Guo, H.; Slager, J.J.; de Bruin, J.W.; van Vliet, A.L.; Blomen, V.A.; et al. Enterovirus D68 receptor requirements unveiled by haploid genetics. Proc. Natl. Acad. Sci. USA 2016, 113, 1399–1404. [CrossRef] [PubMed]
157. Zhang, C.; Zhang, X.; Dai, W.; Liu, Q.; Xiong, P.; Wang, S.; Geng, L.; Gong, S.; Huang, Z. A Mouse Model of Enterovirus D68 Infection for Assessment of the Efficacy of Inactivated Vaccine. Viruses 2018, 10, 58. [CrossRef] [PubMed]
158. Morrey, J.D.; Wang, H.; Hurst, B.L.; Zukor, K.; Siddharthan, V.; Van Wettere, A.J.; Sinex, D.G.; Tarbet, E.B. Causation of Acute Flaccid Paralysis by Myelitis and Myositis in Enterovirus-D68 Infected Mice Deficient in Interferon/Receptor Deficient Mice. Viruses 2018, 10, 33. [CrossRef] [PubMed]
159. McIntosh, K.; Ellis, E.F.; Hoffman, L.S.; Lybass, T.G.; Eller, J.J.; Fulginiti, V.A. The association of viral and bacterial respiratory infections with exacerbations of wheezing in young asthmatic children. J. Pediatr. 1973, 82, 578–590. [CrossRef]
160. Glezen, P.; Denny, F.W. Epidemiology of acute lower respiratory disease in children. N. Engl. J. Med. 1973, 288, 498–505. [CrossRef]
161. Leader, S.; Kohlhase, K. Recent trends in severe respiratory syncytial virus (RSV) among US infants, 1997 to 2000. J. Pediatr. 2003, 143, S127–S132. [CrossRef]
162. Glezen, W.P.; Taber, L.H.; Frank, A.L.; Kasel, J.A. Risk of Primary Infection and Reinfection with Respiratory Syncytial Virus. Am. J. Dis. Child. 1986, 140, 543–546. [CrossRef] [PubMed]
163. Stein, R.; Sherrill, D.; Morgan, W.J.; Holberg, C.J.; Halonen, M.; Taussig, L.M.; Wright, A.L.; Martinez, F.D. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet 1999, 354, 541–545. [CrossRef]
164. Sigurs, N.; Bjarnason, R.; Sigurbergsson, F.; Kjellman, B. Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am. J. Respir. Crit. Care Med. 2000, 161, 1501–1507. [CrossRef] [PubMed]
165. Sigurs, N.; Gustafsson, P.M.; Bjarnason, R.; Lundberg, F.; Schmidt, S.; Sigurbergsson, F.; Kjellman, B. Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13. Am. J. Respir. Crit. Care Med. 2005, 171, 137–141. [CrossRef] [PubMed]
166. Rima, B.; Collins, P.; Easton, A.; Fouchier, R.; Kurath, G.; Lamb, R.A.; Lee, B.; Maisner, A.; Rota, P.; Wang, L.F.; et al. ICTV Virus Taxonomy Profile: Pneumoviridae. J. Gen. Virol. 2017, 98, 2912–2913. [CrossRef] [PubMed]
167. Tayyari, F.; Marchant, D.; Moraes, T.J.; Duan, W.M.; Mastrangelo, P.; Hegele, R.G. Identification of nucleolin as a cellular receptor for human respiratory syncytial virus. Nat. Med. 2011, 17, 1132–1135. [CrossRef] [PubMed]
168. Cirino, N.M.; Panuska, J.R.; Villani, A.; Taraf, H.; Rebert, N.A.; Merolla, R.; Tsivitse, P.; Gilbert, I.A. Restricted Replication of Respiratory Syncytial Virus in Human Alveolar Macrophages. J. Gen. Virol. 1993, 74, 1527–1537. [CrossRef]
169. Blount, R.E., Jr.; Morris, J.A.; Savage, R.E. Recovery of cytopathogenic agent from chimpanzees with coryza. Proc. Soc. Exp. Biol. Med. 1956, 92, 544–549.
170. Belshe, R.B.; Richardson, L.S.; London, W.T.; Sly, D.L.; Lorfeld, J.H.; Camargo, E.; Prevar, D.A.; Chanock, R.M. Experimental respiratory syncytial virus infection of four species of primates. J. Med. Virol. 1977, 1, 157–162. [CrossRef]
171. Richardson, L.S.; Belshe, R.B.; Sly, D.L.; London, W.T.; Prevar, D.A.; Camargo, E.; Chanock, R.M. Experimental respiratory syncytial virus pneumonia in cebus monkeys. J. Med. Virol. 1978, 2, 45–59. [CrossRef]
172. Richardson, L.S.; Belshe, R.B.; London, W.T.; Sly, D.L.; Prevar, D.A.; Camargo, E.; Chanock, R.M. Evaluation of five temperature-sensitive mutants of respiratory syncytial virus in primates: I. Viral shedding, immunologic response, and associated illness. J. Med. Virol. 1978, 3, 91–100. [CrossRef] [PubMed]
173. Taylor, G. Animal models of respiratory syncytial virus infection. Vaccine 2017, 35, 469–480. [CrossRef] [PubMed]
174. Dakhama, A.; Vitalis, T.Z.; Hegele, R.G. Persistence of respiratory syncytial virus (RSV) infection and development of RSV-specific IgG1 response in a guinea-pig model of acute bronchiolitis. Eur. Respir. J. 1997, 10, 20–26. [CrossRef] [PubMed]
175. Bramley, A.M.; Khan, M.A.; Manson, H.E.; Hegele, R.G. Development of respiratory syncytial virus “bronchiolitis” in guinea pigs does not reflect an allergic predisposition in the host. Chest 2003, 124, 671–681. [CrossRef] [PubMed]
176. Robinson, P.J.; Hegele, R.G.; Schellenberg, R.R. Allergic sensitization increases airway reactivity in guinea pigs with respiratory syncytial virus bronchiolitis. J. Allergy Clin. Immunol. 1997, 100, 492–498. [CrossRef]
177. Chan, K.F.; Carolan, L.A.; Druce, J.; Chappell, K.; Watterson, D.; Young, P.; Korenkov, D.; Subbarao, K.; Barr, I.G.; Laurie, K.L.; et al. Pathogenesis, Humoral Immune Responses, and Transmission between Cohoused Animals in a Ferret Model of Human Respiratory Syncytial Virus Infection. J. Virol. 2018, 92, e01322-17. [CrossRef]
178. Prince, G.A.; Hemming, V.G.; Horswood, R.L.; Baron, P.A.; Chanock, R.M. Effectiveness of topically administered neutralizing antibodies in experimental immunotherapy of respiratory syncytial virus infection in cotton rats. J. Virol. 1987, 61, 1851–1854.
179. Cullen, L.M.; Blanco, J.C.G.; Morrison, T.G. Cotton rat immune responses to virus-like particles containing the pre-fusion form of respiratory syncytial virus fusion protein. J. Transl. Med. 2015, 13, 350. [CrossRef]
180. Stobart, C.C.; Rostad, C.A.; Ke, Z.L.; Dillard, R.S.; Hampton, C.M.; Strauss, J.D.; Yi, H.; Hotard, A.L.; Meng, J.; Pickles, R.J.; et al. A live RSV vaccine with engineered thermostability is immunogenic in cotton rats despite high attenuation. Nat. Commun. 2016, 7, 13916. [CrossRef]
181. Horsfall, F.L.; Hahn, R.G. A Latent Virus in Normal Mice Capable of Producing Pneumonia in Its Natural Host. J. Exp. Med. 1940, 71, 391–408. [CrossRef]
182. Taylor, G.; Thomas, L.H.; Wyld, S.G.; Furze, J.; Sopp, P.; Howard, C.J. Role of T-lymphocyte subsets in recovery from respiratory syncytial virus infection in calves. J. Virol. 1995, 69, 6658–6664. [PubMed]
183. Sacco, R.E.; Durbin, R.K.; Durbin, J.E. Animal models of respiratory syncytial virus infection and disease. Curr. Opin. Virol. 2015, 13, 117–122. [CrossRef] [PubMed]
184. Bem, R.A.; Domachowske, J.B.; Rosenberg, H.F. Animal models of human respiratory syncytial virus disease. Am. J. Physiol. Lung Cell. Mol. Physiol. 2011, 301, L148–L156. [CrossRef] [PubMed]
185. Rameix-Welti, M.A.; Le Goffic, R.; Herve, P.L.; Sourimant, J.; Remot, A.; Riffault, S.; Yu, Q.; Galloux, M.; Gault, E.; Eleouet, J.F. Visualizing the replication of respiratory syncytial virus in cells and in living mice. Nat. Commun. 2014, 5, 5104. [CrossRef] [PubMed]
186. Fuentes, S.; Arenas, D.; Moore, M.M.; Golding, H.; Khurana, S. Development of bioluminescence imaging of respiratory syncytial virus (RSV) in virus-infected live mice and its use for evaluation of therapeutics and vaccines. Vaccine 2017, 35, 694–702. [CrossRef] [PubMed]
187. High, M.; Cho, H.Y.; Marzec, J.; Wiltshire, T.; Verhein, K.C.; Caballero, M.T.; Acosta, P.L.; Ciencewicki, J.; Mccaw, Z.R.; Kobzik, L.; et al. Determinants of host susceptibility to murine respiratory syncytial virus (RSV) disease identify a role for the innate immunity scavenger receptor MARCO gene in human infants. Ebiomedicine 2016, 11, 73–84. [CrossRef] [PubMed]
188. Ruckwardt, T.J.; Malloy, A.M.W.; Gostick, E.; Price, D.A.; Dash, P.; McClaren, J.L.; Thomas, P.G.; Graham, B.S. Neonatal CD8 T-cell Hierarchy Is Distinct from Adults and Is Influenced by Intrinsic T cell Properties in Respiratory Syncytial Virus Infected Mice. PLoS Pathog. 2011, 7, e1002377. [CrossRef]
189. Cormier, S.A.; You, D.H.; Honnegowda, S. The use of a neonatal mouse model to study respiratory syncytial virus infections. Expert Rev. Anti-Infect. Ther. 2010, 8, 1371–1380. [CrossRef]
190. Empey, K.M.; Orend, J.G.; Peebles, R.S.; Egana, L.; Norris, K.A.; Oury, T.D.; Kolls, J.K. Stimulation of Immature Lung Macrophages with Intranasal Interferon Gamma in a Novel Neonatal Mouse Model of Respiratory Syncytial Virus Infection. PLoS ONE 2012, 7, e40499. [CrossRef]
191. Li, F.A.; Zhu, H.Q.; Sun, R.; Wei, H.M.; Tian, Z.G. Natural Killer Cells Are Involved in Acute Lung Immune Injury Caused by Respiratory Syncytial Virus Infection. J. Virol. 2012, 86, 2251–2258. [CrossRef]
192. Liu, J.; Haddad, E.K.; Marceau, J.; Morabito, K.M.; Rao, S.S.; Filali-Mouhim, A.; Sekaly, R.P.; Graham, B.S. A Numerically Subdominant CD8 T Cell Response to Matrix Protein of Respiratory Syncytial Virus Controls Infection with Limited Immunopathology. PLoS Pathog. 2016, 12, e1005486. [CrossRef] [PubMed]
193. Schmidt, M.E.; Knudson, C.J.; Hartwig, S.M.; Pewe, L.L.; Meyerholz, D.K.; Langlois, R.A.; Harty, J.T.; Varga, S.M. Memory CD8 T cells mediate severe immunopathology following respiratory syncytial virus infection. PLoS Pathog. 2018, 14, e1006810. [CrossRef] [PubMed]
194. Kinnear, E.; Lambert, L.; McDonald, J.U.; Cheeseman, H.M.; Caproni, L.J.; Tregoning, J.S. Airway T cells protect against RSV infection in the absence of antibody. Mucosal Immunol. 2018, 11, 249–256. [CrossRef] [PubMed]
195. Jozwik, A.; Habibi, M.S.; Paras, A.; Zhu, J.; Guvenel, A.; Dhariwal, J.; Almond, M.; Wong, E.H.C.; Sykes, A.; Maybeno, M.; et al. RSV-specific airway resident memory CD8+T cells and differential disease severity after experimental human infection. Nat. Commun. 2015, 6, 10224. [CrossRef] [PubMed]
196. Zhang, L.; Li, H.Y.; Hai, Y.; Yin, W.; Li, W.J.; Zheng, B.Y.; Du, X.M.; Li, N.; Zhang, Z.Z.; Deng, Y.Q.; et al. CpG in Combination with an Inhibitor of Notch Signaling Suppresses Formalin-Inactivated Respiratory Syncytial Virus-Enhanced Airway Hyperresponsiveness and Inflammation by Inhibiting Th17 Memory Responses and Promoting Tissue-Resident Memory Cells in Lungs. J. Virol. 2017, 91, e02111-16. [CrossRef] [PubMed]
197. Fulton, R.B.; Meyerholz, D.K.; Varga, S.M. Foxp3(+) CD4 Regulatory T Cells Limit Pulmonary Immunopathology by Modulating the CD8 T Cell Response during Respiratory Syncytial Virus Infection. J. Immunol. 2010, 185, 2382–2392. [CrossRef] [PubMed]
198. Ruckwardt, T.J.; Bonaparte, K.L.; Nason, M.C.; Graham, B.S. Regulatory T Cells Promote Early Influx of CD8(+) T Cells in the Lungs of Respiratory Syncytial Virus-Infected Mice and Diminish Immunodominance Disparities. J. Virol. 2009, 83, 3019–3028. [CrossRef] [PubMed]
199. Lee, D.C.P.; Harker, J.A.E.; Tregoning, J.S.; Atabani, S.F.; Johansson, C.; Schwarze, J.; Openshaw, P.J.M. CD25(+) Natural Regulatory T Cells Are Critical in Limiting Innate and Adaptive Immunity and Resolving Disease following Respiratory Syncytial Virus Infection. J. Virol. 2010, 84, 8790–8798. [CrossRef]
200. Durant, L.R.; Makris, S.; Voorburg, C.M.; Loebbermann, J.; Johansson, C.; Openshaw, P.J. Regulatory T cells prevent Th2 immune responses and pulmonary eosinophilia during respiratory syncytial virus infection in mice. J. Virol. 2013, 87, 10946–10954. [CrossRef]
201. Ruckwardt, T.J.; Malloy, A.M.W.; Morabito, K.M.; Graham, B.S. Quantitative and Qualitative Deficits in Neonatal Lung-Migratory Dendritic Cells Impact the Generation of the CD8+T Cell Response. PLoS Pathog. 2014, 10, e1003934. [CrossRef]
202. Lynch, J.P.; Werder, R.B.; Loh, Z.X.; Sikder, M.A.; Curren, B.; Zhang, V.V.; Rogers, M.J.; Lane, K.; Simpson, J.; Mazzone, S.B.; et al. Plasmacytoid dendritic cells protect from viral bronchiolitis and asthma through semaphorin 4a-mediated T reg expansion. J. Exp. Med. 2018, 215, 537–557. [CrossRef] [PubMed]
203. Roman, M.; Calhoun, W.J.; Hinton, K.L.; Avendano, L.F.; Simon, V.; Escobar, A.M.; Gaggero, A.; Diaz, P.V. Respiratory syncytial virus infection in infants is associated with predominant Th-2-like response. Am. J. Respir. Crit. Care Med. 1997, 156, 190–195. [CrossRef] [PubMed]
204. Pala, P.; Bjarnason, R.; Sigurbergsson, F.; Metcalfe, C.; Sigurs, N.; Openshaw, P.J.M. Enhanced IL-4 responses in children with a history of respiratory syncytial virus bronchiolitis in infancy. Eur. Respir. J. 2002, 20, 376–382. [CrossRef] [PubMed]
205. Srikiatkhachorn, A.; Braciale, T.J. Virus-specific CD8+ T lymphocytes downregulate T helper cell type 2 cytokine secretion and pulmonary eosinophilia during experimental murine respiratory syncytial virus infection. J. Exp. Med. 1997, 186, 421–432. [CrossRef] [PubMed]
206. Hussell, T.; Openshaw, P.J. IL-12-activated NK cells reduce lung eosinophilia to the attachment protein of respiratory syncytial virus but do not enhance the severity of illness in CD8 T cell-immunodeficient conditions. J. Immunol. 2000, 165, 7109–7115. [CrossRef] [PubMed]
207. Herlocher, M.L.; Ewasyshyn, M.; Sambhara, S.; Gharaee-Kermani, M.; Cho, D.; Lai, J.; Klein, M.; Maassab, H.F. Immunological properties of plaque purified strains of live attenuated respiratory syncytial virus (RSV) for human vaccine. Vaccine 1999, 17, 172–181. [CrossRef]
208. Lukacs, N.W.; Moore, M.L.; Rudd, B.D.; Berlin, A.A.; Collins, R.D.; Olson, S.J.; Ho, S.B.; Peebles, R.S., Jr. Differential immune responses and pulmonary pathophysiology are induced by two different strains of respiratory syncytial virus. Am. J. Pathol. 2006, 169, 977–986. [CrossRef]
209. Moore, M.L.; Chi, M.H.; Luongo, C.; Lukacs, N.W.; Polosukhin, V.V.; Huckabee, M.M.; Newcomb, D.C.; Buchholz, U.J.; Crowe, J.E., Jr.; Goleniewska, K.; et al. A chimeric A2 strain of respiratory syncytial virus (RSV) with the fusion protein of RSV strain line 19 exhibits enhanced viral load, mucus, and airway dysfunction. J. Virol. 2009, 83, 4185–4194. [CrossRef]
210. Fujimura, K.E.; Demoor, T.; Rauch, M.; Faruqi, A.A.; Jang, S.; Johnson, C.C.; Boushey, H.A.; Zoratti, E.; Ownby, D.; Lukacs, N.W.; et al. House dust exposure mediates gut microbiome Lactobacillus enrichment and airway immune defense against allergens and virus infection. Proc. Natl. Acad. Sci. USA 2014, 111, 805–810. [CrossRef]
211. Petersen, B.C.; Dolgachev, V.; Rasky, A.; Lukacs, N.W. IL-17E (IL-25) and IL-17RB promote respiratory syncytial virus-induced pulmonary disease. J. Leukoc. Biol. 2014, 95, 809–815. [CrossRef]
212. Lee, H.C.; Headley, M.B.; Loo, Y.M.; Berlin, A.; Gale, M.; Debley, J.S.; Lukacs, N.W.; Ziegler, S.F. Thymic stromal lymphopoietin is induced by respiratory syncytial virus-infected airway epithelial cells and promotes a type 2 response to infection. J. Allergy Clin. Immunol. 2012, 130, 1187–1196. [CrossRef]
213. Stier, M.T.; Goleniewska, K.; Cephus, J.Y.; Newcomb, D.C.; Sherrill, T.P.; Boyd, K.L.; Bloodworth, M.H.; Moore, M.L.; Chen, K.; Kolls, J.K.; et al. STAT1 Represses Cytokine-Producing Group 2 and Group 3 Innate Lymphoid Cells during Viral Infection. J. Immunol. 2017, 199, 510–519. [CrossRef]
214. Peebles, R.S.; Sheller, J.R.; Johnson, J.E.; Mitchell, D.B.; Graham, B.S. Respiratory syncytial virus infection prolongs methacholine-induced airway hyperresponsiveness in ovalbumin-sensitized mice. J. Med. Virol. 1999, 57, 186–192. [CrossRef]
215. Hashimoto, K.; Graham, B.S.; Ho, S.B.; Adler, K.B.; Collins, R.D.; Olson, S.J.; Zhou, W.; Suzutani, T.; Jones, P.W.; Goleniewska, K.; et al. Respiratory syncytial virus in allergic lung inflammation increases Muc5ac and gob-5. Am. J. Respir. Crit. Care Med. 2004, 170, 306–312. [CrossRef]
216. Newcomb, D.C.; Boswell, M.G.; Reiss, S.; Zhou, W.; Goleniewska, K.; Toki, S.; Harintho, M.T.; Lukacs, N.W.; Kolls, J.K.; Peebles, R.S., Jr. IL-17A inhibits airway reactivity induced by respiratory syncytial virus infection during allergic airway inflammation. Thorax 2013, 68, 717–723. [CrossRef] [PubMed]
217. Mori, H.; Parker, N.S.; Rodrigues, D.; Hulland, K.; Chappell, D.; Hincks, J.S.; Bright, H.; Evans, S.M.; Lamb, D.J. Differences in respiratory syncytial virus and influenza infection in a house-dust-mite-induced asthma mouse model: Consequences for steroid sensitivity. Clin. Sci. 2013, 125, 565–574. [CrossRef] [PubMed]
218. Lukacs, N.W.; Tekkanat, K.K.; Berlin, A.; Hogaboam, C.M.; Miller, A.; Evanoff, H.; Lincoln, P.; Maassab, H. Respiratory syncytial virus predisposes mice to augmented allergic airway responses via IL-13-mediated mechanisms. J. Immunol. 2001, 167, 1060–1065. [CrossRef]
219. Knudson, C.J.; Weiss, K.A.; Hartwig, S.M.; Varga, S.M. The Pulmonary Localization of Virus-Specific T Lymphocytes Is Governed by the Tissue Tropism of Infection. J. Virol. 2014, 88, 9010–9016. [CrossRef]
220. Eichinger, K.M.; Kosanovich, J.L.; Empey, K.M. Localization of the T-cell response to RSV infection is altered in infant mice. Pediatr. Pulmonol. 2018, 53, 145–153. [CrossRef]
221. Fulton, R.B.; Weiss, K.A.; Pewe, L.L.; Harty, J.T.; Varga, S.M. Aged Mice Exhibit a Severely Diminished CD8 T Cell Response following Respiratory Syncytial Virus Infection. J. Virol. 2013, 87, 12694–12700. [CrossRef]
222. Malloy, A.M.; Ruckwardt, T.J.; Morabito, K.M.; Lau-Kilby, A.W.; Graham, B.S. Pulmonary Dendritic Cell Subsets Shape the Respiratory Syncytial Virus-Specific CD8+ T Cell Immunodominance Hierarchy in Neonates. J. Immunol. 2017, 198, 394–403. [CrossRef] [PubMed]
223. Ruckwardt, T.J.; Morabito, K.M.; Bar-Haim, E.; Nair, D.; Graham, B.S. Neonatal mice possess two phenotypically and functionally distinct lung-migratory CD103(+) dendritic cell populations following respiratory infection. Mucosal Immunol. 2018, 11, 186–198. [CrossRef] [PubMed]
224. Dakhama, A.; Park, J.W.; Taube, C.; Joetham, A.; Balhorn, A.; Miyahara, N.; Takeda, K.; Gelfand, E.W. The enhancement or prevention of airway hyperresponsiveness during reinfection with respiratory syncytial virus is critically dependent on the age at first infection and IL-13 production. J. Immunol. 2005, 175, 1876–1883. [CrossRef] [PubMed]
225. Saravia, J.; You, D.; Shrestha, B.; Jaligama, S.; Siefker, D.; Lee, G.I.; Harding, J.N.; Jones, T.L.; Rovnaghi, C.; Bagga, B.; et al. Respiratory Syncytial Virus Disease Is Mediated by Age-Variable IL-33. PLoS Pathog. 2015, 11, e1005217. [CrossRef] [PubMed]
226. Harker, J.A.; Yamaguchi, Y.; Culley, F.J.; Tregoning, J.S.; Openshaw, P.J.M. Delayed Sequelae of Neonatal Respiratory Syncytial Virus Infection Are Dependent on Cells of the Innate Immune System. J. Virol. 2014, 88, 604–611. [CrossRef]
227. Tregoning, J.S.; Yamaguchi, Y.; Harker, J.; Wang, B.; Openshaw, P.J.M. The role of T cells in the enhancement of respiratory syncytial virus infection severity during adult reinfection of neonatally sensitized mice. J. Virol. 2008, 82, 4115–4124. [CrossRef]
228. Pribul, P.K.; Harker, J.; Wang, B.; Wang, H.; Tregoning, J.S.; Schwarze, J.; Openshaw, P.J. Alveolar macrophages are a major determinant of early responses to viral lung infection but do not influence subsequent disease development. J. Virol. 2008, 82, 4441–4448. [CrossRef]
229. Tregoning, J.S.; Yamaguchi, Y.; Wang, B.; Mihm, D.; Harker, J.A.; Bushell, E.S.C.; Zheng, M.; Liao, G.C.; Peltz, G.; Openshaw, P.J.M. Genetic Susceptibility to the Delayed Sequelae of Neonatal Respiratory Syncytial Virus Infection Is MHC Dependent. J. Immunol. 2010, 185, 5384–5391. [CrossRef]
230. Cormier, S.A.; Shrestha, B.; Saravia, J.; Lee, G.I.; Shen, L.; DeVincenzo, J.P.; Kim, Y.I.; You, D.H. Limited Type I Interferons and Plasmacytoid Dendritic Cells during Neonatal Respiratory Syncytial Virus Infection Permit Immunopathogenesis upon Reinfection. J. Virol. 2014, 88, 9350–9360. [CrossRef]
231. Srinivasa, B.T.; Restori, K.H.; Shan, J.C.; Cyr, L.; Xing, L.; Lee, S.; Ward, B.J.; Fixman, E.D. STAT6 inhibitory peptide given during RSV infection of neonatal mice reduces exacerbated airway responses upon adult reinfection. J. Leukoc. Biol. 2017, 101, 519–529. [CrossRef]
232. You, D.H.; Becnel, D.; Wang, K.; Ripple, M.; Daly, M.; Cormier, S.A. Exposure of neonates to Respiratory Syncytial Virus is critical in determining subsequent airway response in adults. Respir. Res. 2006, 7, 107. [CrossRef] [PubMed]
233. Wang, D.; Bai, S.; Cui, Y.; Zhao, N.; Qi, F.; Liu, J.; Zeng, S.; Xu, L.; Hu, H.; Liu, B. Respiratory syncytial virus prevents the subsequent development of ovalbumin-induced allergic responses by inhibiting ILC2 via the IL-33/ST2 pathway. Immunotherapy 2018, 10, 1065–1076. [CrossRef] [PubMed]
234. Krishnamoorthy, N.; Khare, A.; Oriss, T.B.; Raundhal, M.; Morse, C.; Yarlagadda, M.; Wenzel, S.E.; Moore, M.L.; Peebles, R.S.; Ray, A.; et al. Early infection with respiratory syncytial virus impairs regulatory T cell function and increases susceptibility to allergic asthma. Nat. Med. 2012, 18, 1525–1530. [CrossRef] [PubMed]
235. Davidson, S.; Kaiko, G.; Loh, Z.; Lalwani, A.; Zhang, V.; Spann, K.; Foo, S.Y.; Hansbro, N.; Uematsu, S.; Akira, S.; et al. Plasmacytoid dendritic cells promote host defense against acute pneumovirus infection via the TLR7-MyD88-dependent signaling pathway. J. Immunol. 2011, 186, 5938–5948. [CrossRef] [PubMed]
236. Lynch, J.P.; Werder, R.B.; Simpson, J.; Loh, Z.; Zhang, V.; Haque, A.; Spann, K.; Sly, P.D.; Mazzone, S.B.; Upham, J.W.; et al. Aeroallergen-induced IL-33 predisposes to respiratory virus-induced asthma by dampening antiviral immunity. J. Allergy Clin. Immunol. 2016, 138, 1326–1337. [CrossRef] [PubMed]
237. Van den Hoogen, B.G.; de Jong, J.C.; Groen, J.; Kuiken, T.; de Groot, R.; Fouchier, R.A.; Osterhaus, A.D. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat. Med. 2001, 7, 719–724. [CrossRef] [PubMed]
238. Jartti, T.; van den Hoogen, B.; Garofalo, R.P.; Osterhaus, A.D.; Ruuskanen, O. Metapneumovirus and acute wheezing in children. Lancet 2002, 360, 1393–1394. [CrossRef]
239. Boivin, G.; Abed, Y.; Pelletier, G.; Ruel, L.; Moisan, D.; Cote, S.; Peret, T.C.T.; Erdman, D.D.; Anderson, L.J. Virological features and clinical manifestations associated with human metapneumovirus: A new paramyxovirus responsible for acute respiratory-tract infections in all age groups. J. Infect. Dis. 2002, 186, 1330–1334. [CrossRef] [PubMed]
240. Van den Hoogen, B.G.; van Doornum, G.J.J.; Fockens, J.C.; Cornelissen, J.J.; Beyer, W.E.P.; de Groot, R.; Osterhaus, A.D.M.E.; Fouchier, R.A.M. Prevalence and clinical symptoms of human metapneumovirus infection in hospitalized patients. J. Infect. Dis. 2003, 188, 1571–1577. [CrossRef] [PubMed]
241. Falsey, A.R.; Erdman, D.; Anderson, L.J.; Walsh, E.E. Human metapneumovirus infections in young and elderly adults. J. Infect. Dis. 2003, 187, 785–790. [CrossRef] [PubMed]
242. Williams, J.V.; Crowe, J.E., Jr.; Enriquez, R.; Minton, P.; Peebles, R.S., Jr.; Hamilton, R.G.; Higgins, S.; Griffin, M.; Hartert, T.V. Human metapneumovirus infection plays an etiologic role in acute asthma exacerbations requiring hospitalization in adults. J. Infect. Dis. 2005, 192, 1149–1153. [CrossRef] [PubMed]
243. Williams, J.V.; Harris, P.A.; Tollefson, S.J.; Halburnt-Rush, L.L.; Pingsterhaus, J.M.; Edwards, K.M.; Wright, P.F.; Crowe, J.E. Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children. N. Engl. J. Med. 2004, 350, 443–450. [CrossRef] [PubMed]
244. Van den Hoogen, B.G.; Bestebroer, T.M.; Osterhaus, A.D.M.E.; Fouchier, R.A.M. Analysis of the genomic sequence of a human metapneumovirus. Virology 2002, 295, 119–132. [CrossRef]
245. Kuiken, T.; van den Hoogen, B.G.; van Riel, D.A.; Laman, J.D.; van Amerongen, G.; Sprong, L.; Fouchier, R.A.; Osterhaus, A.D. Experimental human metapneumovirus infection of cynomolgus macaques (Macaca fascicularis) results in virus replication in ciliated epithelial cells and pneumocytes with associated lesions throughout the respiratory tract. Am. J. Pathol. 2004, 164, 1893–1900. [CrossRef]
246. Alvarez, R.; Tripp, R.A. The immune response to human metapneumovirus is associated with aberrant immunity and impaired virus clearance in BALB/c mice. J. Virol. 2005, 79, 5971–5978. [CrossRef] [PubMed]
247. Darniot, M.; Petrella, T.; Aho, S.; Pothier, P.; Manoha, C. Immune response and alteration of pulmonary function after primary human metapneumovirus (hMPV) infection of BALB/c mice. Vaccine 2005, 23, 4473–4480. [CrossRef]
248. Herd, K.A.; Nelson, M.; Mahalingam, S.; Tindle, R.W. Pulmonary infection of mice with human metapneumovirus induces local cytotoxic T-cell and immunoregulatory cytokine responses similar to those seen with human respiratory syncytial virus. J. Gen. Virol. 2010, 91, 1302–1310. [CrossRef]
249. Cheemarla, N.R.; Banos-Lara, M.D.; Naidu, S.; Guerrero-Plata, A. Neutrophils regulate the lung inflammatory response via gamma delta T cell infiltration in an experimental mouse model of human metapneumovirus infection. J. Leukoc. Biol. 2017, 101, 1383–1392. [CrossRef]
250. Kolli, D.; Bataki, E.L.; Spetch, L.; Guerrero-Plata, A.; Jewell, A.M.; Piedra, P.A.; Milligan, G.N.; Garofalo, R.P.; Casola, A. T lymphocytes contribute to antiviral immunity and pathogenesis in experimental human metapneumovirus infection. J. Virol. 2008, 82, 8560–8569. [CrossRef]
251. Darniot, M.; Pitoiset, C.; Petrella, T.; Aho, S.; Pothier, P.; Manoha, C. Age-Associated Aggravation of Clinical Disease after Primary Metapneumovirus Infection of BALB/c Mice. J. Virol. 2009, 83, 3323–3332. [CrossRef]
252. Huck, B.; Neumann-Haefelin, D.; Schmitt-Graeff, A.; Weckmann, M.; Mattes, J.; Ehl, S.; Falcone, V. Human metapneumovirus induces more severe disease and stronger innate immune response in BALB/c mice as compared with respiratory syncytial virus. Respir. Res. 2007, 8, 6. [CrossRef] [PubMed]
253. Hamelin, M.E.; Couture, C.; Sackett, M.K.; Boivin, G. Enhanced lung disease and Th2 response following human metapneumovirus infection in mice immunized with the inactivated virus. J. Gen. Virol. 2007, 88, 3391–3400. [CrossRef] [PubMed]
254. Lay, M.K.; Céspedes, P.F.; Palavecino, C.E.; León, M.A.; Díaz, R.A.; Salazar, F.J.; Méndez, G.P.; Bueno, S.M.; Kalergis, A.M. Human metapneumovirus infection activates the TSLP pathway that drives excessive pulmonary inflammation and viral replication in mice. Eur. J. Immunol. 2015, 45, 1680–1695. [CrossRef] [PubMed]
255. Amarasinghe, G.K.; Bao, Y.; Basler, C.F.; Bavari, S.; Beer, M.; Bejerman, N.; Blasdell, K.R.; Bochnowski, A.; Briese, T.; Bukreyev, A. et al. Taxonomy of the order Mononegavirales: Update 2017. Arch. Virol. 2017, 162, 2493–2504. [CrossRef] [PubMed]
256. Chanock, R.M.; Parrott, R.H.; Cook, K.; Andrews, B.E.; Bell, J.A.; Reichelderfer, T.; Kapikian, A.Z.; Mastrota, F.M.; Huebner, R.J. Newly recognized myxoviruses from children with respiratory disease. N. Engl. J. Med. 1958, 258, 207–213. [CrossRef] [PubMed]
257. Canchola, J.; Christmann, E.; Kim, H.W.; Parrott, R.H.; Chanock, R.M.; Vargosko, A.J.; Jeffries, B. Antigenic Variation among Newly Isolated Strains of Parainfluenza Type 4 Virus. Am. J. Hyg. 1964, 79, 357–364. [PubMed]
258. Henrickson, K.J.; Savatski, L.L. Two distinct human parainfluenza virus type 1 genotypes detected during the 1991 Milwaukee epidemic. J. Clin. Microbiol. 1996, 34, 695–700.
259. Prinoski, K.; Cote, M.J.; Kang, C.Y.; Dimock, K. Evolution of the fusion protein gene of human parainfluenza virus 3. Virus Res. 1992, 22, 55–69. [CrossRef]
260. Henrickson, K.J.; Kuhn, S.M.; Savatski, L.L. Epidemiology and cost of infection with human parainfluenza virus types 1 and 2 in young children. Clin. Infect. Dis. 1994, 18, 770–779. [CrossRef]
261. Fiore, A.E.; Iverson, C.; Messmer, T.; Erdman, D.; Lett, S.M.; Talkington, D.F.; Anderson, L.J.; Fields, B.; Carlone, G.M.; Breiman, R.F.; et al. Outbreak of pneumonia in a long-term care facility: Antecedent human parainfluenza virus 1 infection may predispose to bacterial pneumonia. J. Am. Geriatr. Soc. 1998, 46, 1112–1117. [CrossRef]
262. Prince, G.A.; Porter, D.D. Treatment of parainfluenza virus type 3 bronchiolitis and pneumonia in a cotton rat model using topical antibody and glucocorticosteroid. J. Infect. Dis. 1996, 173, 598–608. [CrossRef] [PubMed]
263. Downham, M.A.P.; Mcquillin, J.; Gardner, P.S. Diagnosis and Clinical Significance of Parainfluenza Virus-Infections in Children. Arch. Dis. Child. 1974, 49, 8–15. [CrossRef] [PubMed]
264. Weinberg, G.A.; Hall, C.B.; Iwane, M.K.; Poehling, K.A.; Edwards, K.M.; Griffin, M.R.; Staat, M.A.; Curns, A.T.; Erdman, D.D.; Szilagyi, P.G.; et al. Parainfluenza Virus Infection of Young Children: Estimates of the Population-Based Burden of Hospitalization. J. Pediatr. 2009, 154, 694–699. [CrossRef] [PubMed]
265. Mao, N.Y.; Ji, Y.X.; Xie, Z.D.; Wang, H.H.; Wang, H.L.; An, J.J.; Zhang, X.X.; Zhang, Y.; Zhu, Z.; Cui, A.L.; et al. Human Parainfluenza Virus-Associated Respiratory Tract Infection among Children and Genetic Analysis of HPIV-3 Strains in Beijing, China. PLoS ONE 2012, 7, e0043893. [CrossRef] [PubMed]
266. Simmonds, A.; Munoz, J.; Montecalvo, M.; Clones, B.; LaGamma, E.F. Outbreak of Parainfluenza Virus Type 3 in a Neonatal Intensive Care Unit. Am. J. Perinat. 2009, 26, 361–364. [CrossRef] [PubMed]
267. Costa, L.D.C.; Camargos, P.A.M.; Brand, P.L.P.; Fiaccadori, F.S.; Souza, M.B.D.D.E.; Cardoso, D.D.D.; Castro, I.D.; Minamisavas, R.; da Costa, P.S.S. Asthma exacerbations in a subtropical area and the role of respiratory viruses: A cross-sectional study. BMC Pulm. Med. 2018, 18, 109. [CrossRef] [PubMed]
268. Wang, F.; Zhao, L.Q.; Zhu, R.N.; Deng, J.; Sun, Y.; Ding, Y.X.; Tian, R.; Qian, Y. Parainfluenza Virus Types 1, 2, and 3 in Pediatric Patients with Acute Respiratory Infections in Beijing During 2004 to 2012. Chin. Med. J. 2015, 128, 2726–2730.
269. Matsuse, H.; Kondo, Y.; Saeki, S.; Nakata, H.; Fukushima, C.; Mizuta, Y.; Kohno, S. Naturally occurring parainfluenza virus 3 infection in adults induces mild exacerbation of asthma associated with increased sputum concentrations of cysteinyl leukotrienes. Int. Arch. Allergy Immunol. 2005, 138, 267–272. [CrossRef] [PubMed]
270. Ottolini, M.G.; Porter, D.D.; Blanco, J.C.; Prince, G.A. A cotton rat model of human parainfluenza 3 laryngotracheitis: Virus growth, pathology, and therapy. J. Infect. Dis. 2002, 186, 1713–1717. [CrossRef] [PubMed]
271. Mascoli, C.C.; Gower, T.A.; Capilupo, F.A.; Metzgar, D.P. Further studies on the neonatal ferret model of infection and immunity to and attenuation of human parainfluenza viruses. Dev. Biol. Stand. 1976, 33, 384–390. [PubMed]
272. Chang, P.W.; Hsiung, G.D. Experimental infection of parainfluenza virus type 5 in mice, hamsters and monkeys. J. Immunol. 1965, 95, 591–601. [PubMed]
273. Burke, C.W.; Bridges, O.; Brown, S.; Rahija, R.; Russell, C.J. Mode of parainfluenza virus transmission determines the dynamics of primary infection and protection from reinfection. PLoS Pathog. 2013, 9, e1003786. [CrossRef] [PubMed]
274. Akk, A.M.; Simmons, P.M.; Chan, H.W.; Agapov, E.; Holtzman, M.J.; Grayson, M.H.; Pham, C.T. Dipeptidyl peptidase I-dependent neutrophil recruitment modulates the inflammatory response to Sendai virus infection. J. Immunol. 2008, 180, 3535–3542. [CrossRef] [PubMed]
275. McWilliam, A.S.; Marsh, A.M.; Holt, P.G. Inflammatory infiltration of the upper airway epithelium during Sendai virus infection: Involvement of epithelial dendritic cells. J. Virol. 1997, 71, 226–236. [PubMed]
276. Grayson, M.H.; Ramos, M.S.; Rohlfing, M.M.; Kitchens, R.; Wang, H.D.; Gould, A.; Agapov, E.; Holtzman, M.J. Controls for lung dendritic cell maturation and migration during respiratory viral infection. J. Immunol. 2007, 179, 1438–1448. [CrossRef]
277. Kim, E.Y.; Battaile, J.T.; Patel, A.C.; You, Y.; Agapov, E.; Grayson, M.H.; Benoit, L.A.; Byers, D.E.; Alevy, Y.; Tucker, J.; et al. Persistent activation of an innate immune response translates respiratory viral infection into chronic lung disease. Nat. Med. 2008, 14, 633–640. [CrossRef]
278. Grayson, M.H.; Cheung, D.; Rohlfing, M.M.; Kitchens, R.; Spiegel, D.E.; Tucker, J.; Battaile, J.T.; Alevy, Y.; Yan, L.; Agapov, E.; et al. Induction of high-affinity IgE receptor on lung dendritic cells during viral infection leads to mucous cell metaplasia. J. Exp. Med. 2007, 204, 2759–2769. [CrossRef]
279. Cheung, D.S.; Ehlenbach, S.J.; Kitchens, R.T.; Riley, D.A.; Thomas, L.L.; Holtzman, M.J.; Grayson, M.H. Cutting Edge: CD49d+ Neutrophils Induce FcεRI Expression on Lung Dendritic Cells in a Mouse Model of Postviral Asthma. J. Immunol. 2010, 185, 4983–4987. [CrossRef]
280. Thomas, M.A.; Buelow, B.J.; Nevins, A.M.; Jones, S.E.; Peterson, F.C.; Gundry, R.L.; Grayson, M.H.; Volkman, B.F. Structure-function analysis of CCL28 in the development of post-viral asthma. J. Biol. Chem. 2015, 290, 4528–4536. [CrossRef]
281. Cheung, D.S.; Sigua, J.A.; Simpson, P.M.; Yan, K.; Hussain, S.R.A.; Santoro, J.L.; Buell, E.J.; Hunter, D.A.; Rohlfing, M.; Patadia, D.; et al. Cysteinyl leukotriene receptor 1 expression identifies a subset of neutrophils during the antiviral response that contributes to postviral atopic airway disease. J. Allergy Clin. Immunol. 2018, 142, 1206–1217. [CrossRef]
282. Mori, I.; Komatsu, T.; Takeuchi, K.; Nakakuki, K.; Sudo, M.; Kimura, Y. Parainfluenza virus type 1 infects olfactory neurons and establishes long-term persistence in the nerve tissue. J. Gen. Virol. 1995, 76 Pt 5, 1251–1254. [CrossRef]
283. Lee, A.M.; Fryer, A.D.; van Rooijen, N.; Jacoby, D.B. Role of macrophages in virus-induced airway hyperresponsiveness and neuronal M2 muscarinic receptor dysfunction. Am. J. Physiol. Lung Cell Mol. Physiol. 2004, 286, L1255–L1259. [CrossRef] [PubMed]
284. Castleman, W.L.; Sorkness, R.L.; Lemanske, R.F.; Grasee, G.; Suyemoto, M.M. Neonatal Viral Bronchiolitis and Pneumonia Induces Bronchiolar Hypoplasia and Alveolar Dysplasia in Rats. Lab. Investig. 1988, 59, 387–396. [PubMed]
285. Castleman, W.L.; Sorkness, R.L.; Lemanske, R.F., Jr.; McAllister, P.K. Viral bronchiolitis during early life induces increased numbers of bronchiolar mast cells and airway hyperresponsiveness. Am. J. Pathol. 1990, 137, 821–831. [PubMed]
286. Kumar, A.; Sorkness, R.L.; Kaplan, M.R.; Lemanske, R.F., Jr. Chronic, episodic, reversible airway obstruction after viral bronchiolitis in rats. Am. J. Respir. Crit. Care Med. 1997, 155, 130–134. [CrossRef] [PubMed]
287. Sorkness, R.L.; Gern, J.E.; Grindle, K.A.; Mosser, A.G.; Rosenthal, L.A.; Mikus, L.D.; Lemanske, R.F., Jr. Persistence of viral RNA in 2 rat strains differing in susceptibility to postbronchiolitis airway dysfunction. J. Allergy Clin. Immunol. 2002, 110, 607–609. [CrossRef] [PubMed]
288. Mikus, L.D.; Rosenthal, L.A.; Sorkness, R.L.; Lemanske, R.F., Jr. Reduced interferon-gamma secretion by natural killer cells from rats susceptible to postviral chronic airway dysfunction. Am. J. Respir. Cell. Mol. Biol. 2001, 24, 74–82. [CrossRef]
289. Rosenthal, L.A.; Mikus, L.D.; Tuffaha, A.; Mosser, A.G.; Sorkness, R.L.; Lemanske, R.F., Jr. Attenuated innate mechanisms of interferon-gamma production in rats susceptible to postviral airway dysfunction. Am. J. Respir. Cell. Mol. Biol. 2004, 30, 702–709. [CrossRef]
290. Uhl, E.W.; Clarke, T.J.; Hogan, R.J. Differential expression of nuclear factor-kappaB mediates increased pulmonary expression of tumor necrosis factor-alpha and virus-induced asthma. Viral. Immunol. 2009, 22, 79–89. [CrossRef]
291. Uhl, E.W.; Clarke, T.J.; Lester, C.; Hogan, R.J. Rats Susceptible to Virus-Induced Asthma Have a Persistent Virus-Induced Change in the Predominant Pulmonary Form of the NF-kappa B Inhibitor I kappa B alpha. Vet. Pathol. 2010, 47, 1021–1027. [CrossRef]
292. Allander, T.; Tammi, M.T.; Eriksson, M.; Bjerkner, A.; Tiveljung-Lindell, A.; Andersson, B. Cloning of a human parvovirus by molecular screening of respiratory tract samples. Proc. Natl. Acad. Sci. USA 2005, 102, 12891–12896. [CrossRef] [PubMed]
293. Bastien, N.; Brandt, K.; Dust, K.; Ward, D.; Li, Y. Human Bocavirus infection, Canada. Emerg. Infect. Dis. 2006, 12, 848–850. [CrossRef] [PubMed]
294. Lau, S.K.; Yip, C.C.; Que, T.L.; Lee, R.A.; Au-Yeung, R.K.; Zhou, B.; So, L.Y.; Lau, Y.L.; Chan, K.H.; Woo, P.C. et al. Clinical and molecular epidemiology of human bocavirus in respiratory and fecal samples from children in Hong Kong. J. Infect. Dis. 2007, 196, 986–993. [CrossRef] [PubMed]
295. Allander, T.; Jartti, T.; Gupta, S.; Niesters, H.G.; Lehtinen, P.; Osterback, R.; Vuorinen, T.; Waris, M.; Bjerkner, A.; Tiveljung-Lindell, A.; et al. Human bocavirus and acute wheezing in children. Clin. Infect. Dis. 2007, 44, 904–910. [CrossRef] [PubMed]
296. Kesebir, D.; Vazquez, M.; Weibel, C.; Shapiro, E.D.; Ferguson, D.; Landry, M.L.; Kahn, J.S. Human bocavirus infection in young children in the United States: Molecular epidemiological profile and clinical characteristics of a newly emerging respiratory virus. J. Infect. Dis. 2006, 194, 1276–1282. [CrossRef] [PubMed]
297. Vallet, C.; Pons-Catalano, C.; Mandelcwajg, A.; Wang, A.; Raymond, J.; Lebon, P.; Gendrel, D. Human bocavirus: A cause of severe asthma exacerbation in children. J. Pediatr. 2009, 155, 286–288. [CrossRef] [PubMed]
298. Yan, Z.; Feng, Z.; Sun, X.; Zhang, Y.; Zou, W.; Wang, Z.; Jensen-Cody, C.; Liang, B.; Park, S.Y.; Qiu, J.; et al. Human Bocavirus Type-1 Capsid Facilitates the Transduction of Ferret Airways by Adeno-Associated Virus Genomes. Hum. Gene Ther. 2017, 28, 612–625. [CrossRef] [PubMed]
299. Kim, H.Y.; Chang, Y.J.; Subramanian, S.; Lee, H.H.; Albacker, L.A.; Matangkasombut, P.; Savage, P.B.; McKenzie, A.N.; Smith, D.E.; Rottman, J.B.; et al. Innate lymphoid cells responding to IL-33 mediate airway hyperreactivity independently of adaptive immunity. J. Allergy Clin. Immunol. 2012, 129, 216–227. [CrossRef]
300. Juno, J.A.; Keynan, Y.; Fowke, K.R. Invariant NKT Cells: Regulation and Function during Viral Infection. PLoS Pathog. 2012, 8, e1002838. [CrossRef]
301. Morita, H.; Moro, K.; Koyasu, S. Innate lymphoid cells in allergic and nonallergic inflammation. J. Allergy Clin. Immunol. 2016, 138, 1253–1264. [CrossRef]